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 “Inflammatory processes of any nature are soon to be manifested in the reaction of 
microglia. In cases of meningitis and meningoencephalitis the microglia of the affected 
areas undergoes changes corresponding to the early stages of mobilization and phagocytic 









1.1. Barriers in the brain and regulation of immune cell trafficking 
 
While the weight of the brain accounts for only 2% of the total body weight, it consumes 
20% of the total cardiac output. This requires constant energy balance and strictly controlled 
blood flow (autoregulation), as well as rapid adjustment of local perfusion needs to change 
in neuronal activity (functional hyperemia). In addition, for the proper functioning of 
neurons, the brain requires tight metabolic regulation and ion gradients that largely differ 
from the composition of the blood. Vascular injury or brain damage results in the 
dysregulation of proper brain circulation and metabolism, that may lead to irreversible 
neuronal injury. Therefore, the brain is protected by special barriers that allow isolation of 
the brain microenvironment from the peripheral circulation and circulating immune cells.  
The vascular network of the central nervous system (CNS) has evolved to maintain proper 
homeostatic balance inside the parenchyma. Vascular permeability, immune cell trafficking, 
blood flow and vascular tone that are critical for the proper function of CNS is precisely 
controlled (Hanisch and Kettenmann 2007; Daneman 2012). To this end, the blood-brain 
barrier (BBB) is formed by unique blood vessels in the CNS that regulate the movement of 
molecules, ions and immune cells between the blood and neural tissue. The BBB also 
protects the CNS from injury and infection by limiting the entry of pathogens and immune 
cells (Engelhardt & Liebner, 2014). BBB function between the blood and the CNS 
parenchyma is maintained by specialized capillary endothelial cells with low pinocytotic 
activity, fused together by complex tight junctions (Engelhardt and Sorokin 2009; Tietz and 
Engelhardt 2015). The endothelial cells regulate paracellular transport in both directions, but 
transcellular transport is regulated by special pumps and receptors (Archer, Pitelka, & 
Hammond, 2004). The basal lamina of endothelial cells is surrounded by astrocyte endfeet, 
which contributes to the barrier function by limiting the trafficking of macromolecules and 
immune cells. The blood-CSF barrier (BCSFB) is the second interphase that protects the 
CNS, formed by the choroid plexus epithelium which produces and regulates the 
composition of CSF (Prinz, Priller, Sisodia, & Ransohoff, 2011). The barrier function in the 
choroid plexus is provided by tight junctions between epithelial cells (Engelhardt & Sorokin, 
2009). The blood-CSF interface is also an important site for immune cell entry into the CNS, 
where low numbers of different immune cell populations are seen under physiological 




& Hagemeyer, 2017). In homeostatic conditions, peripheral immune cells also patrol in 
specialized CNS compartments located outside the brain parenchyma. Immune cells can also 
gain access to the CNS via the non-fenestrated vascularized stroma of the blood-CSF barrier 
that is surrounded by the choroid plexus epithelial cells, the perivascular space (Virchow-
Robin space; (Ousman and Kubes 2012; Muoio, Persson, and Sendeski 2014). There are also 
specialized regions of the brain that allow direct communication between the brain and the 
vascular system. In the circumventricular organs, located around the third and fourth 
ventricles, the BBB is more permeable, containing fenestrations and discontinous tight 
junctions (Bauer, Krizbai, Bauer, & Traweger, 2014) and these areas are important to 
regulate neuro-immune interactions in health and disease. Recent research revealed that 
similar to the drainage of extracellular fluid in peripheral tissues, the brain also has its 
clearance routes, called the glymphatic system (glial-lymphatic system, (see Figure 1.). This 
is provided by a unique system of perivascular channels formed by astrocytes that promote 
efficient elimination of soluble proteins and metabolites from the CNS. It mainly operates 
as a waste clearance system and its role in brain inflammation and neurological diseases has 
also been suggested (Aspelund et al. 2015; Kipnis et al. 2017). In addition, lymph vessels 
have recently been identified in the meninges, which are emerging sites for neuro-immune 
interactions (Kipnis et al., 2017). At present, it is assumed that immune cells, primarily 
myeloid cell populations, which reside in the brain throughout life can gain access to the 
developing CNS in the first trimester in both mice and humans via both meningeal and 
vascular routes, while the role for the choroid plexus in their migration is also emerging. In 
adults, these areas in the CNS provide functionally important routes of entry for leukocytes 
during brain inflammation or diverse neuropathologies. In physiological conditions, 
meningeal, choroid plexus machrophages and a small amount of T cells patrol continuously 





Figure 1. Barriers of the brain and immune cell trafficking in homeostatic condition. 
The brain is isolated and protected by the skull and three layers of meninges. The choroid 
plexus produces CSF which flows both in the parenchyma and in the subarachnoid area and 
comprises arteries and perivascular space. Thus, the CSF contains small amount of CD4+ T 
cells, which patrol the brain. In healthy brain tissue, leukocytes (granulocytes, monocytes, T 
and B cells) stay within the blood vessels. In the brain parenchyma microglial cells are the 
only immune cells maintaining the healty environment. In non-parenchymal areas 
perivascular, meningeal and choroid plexus machrophages are patrolling and protect the 






1.2. The neurovascular unit 
 
The key area in the brain vasculature that regulates cerebral blood flow and immune cell 
trafficking is called the neurovascular unit (NVU). The NVU is formed via complex 
functional interactions between endothelial cells, pericytes, perivascular macrophages 
(PVMs), microglia, astrocytes and neurons (Figure 2.) (Wong et al., 2013). All those cell 
types are in an integrated relationship and they maintain homeostasis and proper function of 
the CNS (Thurgur & Pinteaux, 2018). The blood-brain barrier can be considered as an 
integral part of the NVU. The low permeability and integrity of endothelial cells is the most 
important feature of CNS protection from blood-borne materials (Tietz & Engelhardt, 2015). 
Astrocytes compose the glia limitans perivascularis, which separates the parenchyma from 
the blood vessels and continues as glia limitans superficialis surrounding the entire surface 
of the brain and spinal cord (Abbott, Rönnbäck, & Hansson, 2006). Astrocytes cover the 
parenchymal basement membrane, produce different growth factors for BBB maturation and 
maintenance and, via aquaporin channels, they can also regulate local water transport 
(Ransohoff & Engelhardt, 2012). Besides BBB maintenance they provide both mechanical 
and metabolic support for neurons (Abbott et al., 2006). Pericytes are embedded in the 
vascular basement membrane of microvessels. Due to their exclusive position, they have 
close contact with endothelial cells, astrocyte endfeet, perivascular macrophages and 
neurons (Rustenhoven, Jansson, Smyth, & Dragunow, 2017a). In the brain, pericytes have 
distinct morphologies and depending on their position in the vasculature have different 
functions as well. In the arteriolar end of vessels, precapillary pericytes are likely to modify 
vascular diameter, and true-capillary pericytes contribute more to BBB maintenance 
(Rustenhoven et al. 2017; Engelhardt 2008).  
The main immunocompetent cell types in the NVU are microglia and perivascular 
macrophages. Since in this thesis the inflammatory- and immune mechanisms discussed in 
the context of neurotropic virus infection primarily concern microglial cells, the chapters 
below will focus on the origin, maintenance and effector functions of brain myeloid cell 





Figure 2. Structure of the blood-brain barrier (BBB) and neurovascular unit (NVU). 
Pial arteries branch out into smaller arteries, called penetrating arteries. They go down into 
the parenchyma, branching further into arterioles and capillaries. Pial and penetrating 
arteries are covered by vascular smooth mucle cells and are separated from the brain 
parenchyma by the glia limitans. Endothelial cells form the blood-brain barrier, which are in 
close contact with other cell types (pericytes, astrocytes, perivascular macrophages and 





1.3. Origin of myeloid cells in the CNS 
 
Myeloid cells in the CNS represent a heterogeneous class of innate immune cells that 
contribute to the maintenance of tissue homeostasis differentially during development and 
adulthood. Myeloid cell types in the adult CNS include microglia, perivascular macrophages 
as well as meningeal and choroid plexus macrophages (Li and Barres 2018; Prinz, Erny, and 
Hagemeyer 2017). The origin and differentiation of CNS macrophages is still under intense 
discussion. However, novel transgenic mouse models and fate mapping studies have shed 
light on the origin of parenchymal microglia and other myeloid cell types. These studies 
have shown that microglia are derived exclusively from prenatal hematopoietic progenitor 
cells that reside in the yolk sac (Ginhoux et al., 2010). Microglia and most myeloid cell types 
in the CNS have self-renewing populations through the whole life (Li & Barres, 2018). 
Microglia are the main immune cell type of the brain. Unlike ectodermal macroglial cells 
such as astrocytes and oligodendrocytes, microglia originate from the yolk sac, an 
extraembryonic mesodermal tissue, which is the first place for early hematopoiesis during 
development. It has been found that microglia arise from an uncommitted CD31+c-kit+ 
erythromyeloid precursor (EMP) cell located in the yolk sac, which further develops via the 
macrophage ancestor population A1 (CD45+CX3CR1loF4/80lo) into the A2 
(CD45+CX3CR1hiF4/80hi) progenitor population. Microglial progenitors migrate from the 
yolk sac during development to the nervous tissue in two waves (Prinz & Priller, 2014b). In 
humans, migration happens during the first two trimesters, in rodents in between embryonic 
days 10 and 19. The second population of microglial cells invades the parenchyma during 
early postnatal days (Hanisch & Kettenmann, 2007). During fetal development, microglial 
progenitors enter the CNS via blood vessels, the ventricles and the meninges (Prinz & 
Mildner, 2011). After their entry into the brain tissue, they migrate first tangentially and 
radially in a Pu.1 and Irf8 dependent manner, then undergo proliferation and apoptosis 
(Pósfai et al. 2018; Nikodemova et al. 2015). For healthy development and maintenance 
microglia need specific receptor and ligand toolkits such as CSF-1R CSF-1 axis, IL-34, Pu.1, 
and TGFß1 which is uniquely expressed by only microglial cells in the CNS (Erblich, Zhu, 
Etgen, Dobrenis, & Pollard, 2011).  
Perivascular macrophages (PVM) are a distinct population of resident brain macrophages 
located in the perivascular (Virchow-Robin space) compartment (Figure 2.) surrounding 
arteries and veins. They migrate from the yolk sac into the brain during early development, 




bone marrow-derived progenitors thorughout life under normal conditions (Faraco, Park, 
Anrather, & Iadecola, 2017). They can influence vascular permeability via restricting the 
movement of solutes, pathogens and immune cell entry from the periphery (Goldmann et al., 
2016). Besides PVMs, there are two other non- parenchymal macrophage populations in 
different CNS compartments, namely the meningeal macrophages (MGM) and choroid 
plexus macrophages. MGMs patrol between the pia mater and surface of the brain and 
originate from the same yolk sac progenitors like PVM and microglia. Choroid plexus 
macrophages however, can be found in ventricles and have both embryonic and adult 
hematopoietic origins (Kierdorf and Prinz 2017; Goldmann et al,. 2016). 
 
1.4. The role of microglia during development and in normal brain function 
 
1.4.1. Developmental role of microglia 
 
Due to their partially common origin with other tissue macrophage populations, it is difficult 
to define the precise contribution of microglia to CNS development. However, increasing 
evidence indicates that the absence or dysfunction of microglia results in severely impaired 
neuronal network development (Stevens & Schafer, 2018). Microglia are known to 
contribute to normal brain development via diverse functions, including phagocytosis of 
dead cells, guiding sprouting blood vessels in the parenchyma, maintanance and elimination 
of synapses or supporting neuronal network organization (Figure 3.). In fact, during 
development, the first microglial progenitors appear in the CNS when functional neuronal 
networks are formed and contact neurons and their processes.  The importance of microglial 
presence was proved by a very rare case, when a child was born with CSF-1R mutation, 
which resulted in the complete absence of microglia in his brain. The absence of microglia 
led to largely deformed ventricles, undeveloped corpus callosum, serious functional deficits 
in general brain functions and eventually early death (Zhang, 2019). Gain-of-function and 
loss-of-functions studies also indicate that microglia are required for the normal 
development of the brain vasculature, ventricles and neuronal networks. Similarly to the 
human case, in CSF-1R deficient mouse model, the absence of microglia, exhibit severe 
defects in brain maturation with marked structural abnormalities, including olfactory bulb 
atrophy, expansion of lateral ventricles and dramatic thinning of the neocortex (Prinz & 
Priller, 2017). During development, microglia contribute to the maintenance of neuronal 




During this process, unwanted synapses are tagged with the complement protein C1q and 
phagocytosed by microglia (Schafer et al. 2012; Pósfai et al. 2018). In C1q knock out mice, 
increased number of axonal boutons of layer V pyramidal cells has been shown, which 
resulted in epileptic neuronal network activity (Rubino et al., 2018). Besides the complement 
system, the Cx3cl1-Cx3cr1 axis is also an essential contributor in synaptic pruning, axonal 
growth, and normal network formation. Cx3cr1, which is a chemokine, also known as 
fractalkine. The deficiency of this Cx3cr1 receptor on microglial cells results in decreased 
survival of neurons in layer V of the neocortex, and also results in impaired network 
maturation (Prinz & Priller, 2017). Apart from phagocytosing synaptic elements and 
apoptotic neurons, microglia also support and promote neuronal survival and migration via 
secreting neurotrophic factors, such as BDNF or IGF-1 (Stevens & Schafer, 2018).  
 
1.4.2. The role of microglia in adulthood 
 
Microglia are distributed over the whole CNS parenchyma. Fate-mapping studies have 
revealed that microglial cells are unique in the sense that they are self-renewing throughout 
life. In the adult brain, microglia occupy distinct non-overlapping territories and constantly 
scan their environment (Davalos et al. 2005; Tremblay et al. 2011). The fine processes of 
microglia continuously contact neurons, axons and dendritic spines to monitor their 
functional status. Microglia are known to sense changes in neuronal activity via altered 
extracellular ion gradients, CX3CL1-CX3CR1 or CD200-CD200R interactions, purinergic 
signaling and other mechanisms that shape synaptic connectivity and neuronal networks 
under physiological and pathological conditions (Kettenmann, Kirchhoff, & Verkhratsky, 
2013). Microglial process motility can change dramatically in response to extracellular 
stimuli, including neuronal activity and exposure to neurotransmitters (Salter & Stevens, 
2017). Recent evidence suggests that the motility of microglia is controlled in part, by Thik1 
potassium channel on the microglial membrane (Madry et al., 2018)  and various purinergic 
receptors (Dissing-Olesen et al. 2014; Eyo et al. 2015). Several studies have noted that ATP 
released by dying cells or actively pumped out of intact cells via connexin or pannexin 
hemichannels, as an inflammatory amplifier induces rapid microglial responses (Färber & 
Kettenmann, 2006). A key feature of microglia in the postnatal brain is the rapid 
identification of dying cells, followed by migration and clearance of apoptotic debris (Wolf, 
Boddeke, and Kettenmann 2017; Peri and Nüsslein-Volhard 2008). Although it is not 




have identified that purinergic receptors, such as metabotropic P2Y12 as a trigger of 
microglial chemotaxis and phagocytosis in response to neuronal injury (Koizumi, Ohsawa, 
Inoue, & Kohsaka, 2013). Besides eliminating dying cells,  microglia regulate the brain 
microenvironment via elimination of excess synaptic elements as well, directed by 
chemotactic signals (e.g. ATP) or phagocytic signals like C1q, and induce apoptosis without 
provoking inflammation (Stevens & Schafer, 2018).  
Several studies are focussing on a large variety of microglial functions during either early 
postnatal phase or adulthood. Analyzing the exact contribution of microglia in controlling 
synaptic plasticity, regulating synaptic properties, especially during learning and circuit 
maturation have been the target of great interest. In order to study these roles, the recent 
development of new tools and approaches have become available. These tools include both 
pharmacological and genetically modified mice to deplete microglia. Pharmacological 
approaches include the administration of clodronate-containing liposomes (Buiting and 
Rooijen 1994)  and the inhibition of the Csf1 signaling pathway, which is crucial for 
microglial survival (Elmore et al. 2014; Squarzoni et al. 2014). Genetic depletion is achieved 
either by removing factors indispensable for microglial maturation and survival such as 
CSF1R, IL-34 and PU.1 or through the expression of ’suicidal genes’, such as diphtheria 
toxin receptor (DTR) or viral thymidine kinase (HSVTK) under the control of specific 
microglial promoters, like CD11b or Cx3cr1 (Paolicelli and Ferretti 2017). However, each 
of these models has been essential for deepening our knowledge of microglial function, each 
system has its own set of drawbacks.  
Elimination of microglia in adulthood via inhibition with small molecules or blocking 
microglia produced brain-derived neurotrophic factor (BDNF), which is a key signaling 
molecule important in synaptic plasticity, has to lead to impaired learning and memory and 
synaptic plasticity (Parkhurst et al. 2013). Those results indicate that microglia serve 
important physiological functions in learning and memory by promoting learning-related 
synapse formation through BDNF signaling (Parkhurst et al. 2013). Depletion of microglia, 
by using Cx3cr1-CreERT2 specific mice, which express diphtheria toxin receptor (DTR) on 
microglia and macrophages followed by timed injection of diphtheria toxin to eliminate 
receptor expressing cells, also revealed that microglia are involved in the elimination and 
formation of dendritic spines in the cortex both during development. Interestingly depletion 
of microglia during adulthood in the same model, induced only reduced synapse formation 
but not elimination (Paolicelli and Ferretti 2017). Such a function of microglia contributes 




own drawbacks since specific microglia depletion via diphtheria toxin administration 
resulted in only 80% elimination of microglial cells. From the remaining surviving 
population they were quickly recuperated by hyper-proliferation (Bruttger et al., 2015). 
Administration of liposome-encapsulated clodronate drug also resulted in microglia 
depletion in ex vivo organotypic hippocampal slices. Similarly to the previous diphtheria 
toxin-induced model, microglia depletion resulted in increased frequency of postsynaptic 
currents, which is consistent with a higher density of synapses (Frieler et al., 2015). 
Replenishment of microglia in the slices restored normal synaptic currents. These results 
indicate that the role of microglia in synapse formation persists throughout life (Parkhurst et 
al., 2013a). Even though ex vivo administration of clodronate works, in vivo injection into 
the parenchymal tissue might induce unwanted inflammatory effects (Han et al., 2019). 
The seemingly efficient microglia depletion model was the development of mice expressing 
the herpes-simplex virus-encoded suicide-gene thymidine kinase (HSVTK) under the 
CD11b-promoter (Heppner et al., 2005). Administration of i.c.v. ganciclovir resulted in up 
to 95% depletion of microglia (Lund, Pieber, & Harris, 2017), however, after extended 
delivery, the drug administration became toxic, thereby limiting this approach to a period of 
4 weeks. Thus, in subsequent studies, it was demonstrated that ganciclovir delivery resulted 
in a complete exchange of the microglial pool by peripheral myeloid cells (Varvel et al. 
2012; Prokop et al., 2015). Furthermore, BBB damage was also reported upon long-term 
administration of ganciclovir, resulting in the infiltration of peripheral immune cell subsets 
(Lund et al., 2017). 
Accumulating evidence from fate-mapping and genomic studies indicates that microglia 
requires CSF1R both during development and adulthood for survival since CSF1R-/- mice 
completely lack microglia (Ginhoux et al. 2010; Elmore et al. 2014). Microglia can use both 
ligands of CSF1R for their survival (CSF1 and IL-34) since mice mutant for either cytokine 
display reduction but not complete loss of microglia (Waisman et al. 2015; Waisman et al. 
2015). Pharmacological inhibition of CSF1R yields complete ablation (>99%) of microglia 
within 21 days. This approach is practical because it requires no mouse breeding and 
microglial depletion can be maintained as long as the drug is administered. Surprisingly, 
microglia depletion via CSF1R inhibitor PLX3397 in adult mice up to 3 weeks did not result 
in major changes in synaptic properties and was not associated with cognitive deficits, 
however, longer administration can alter the synaptic density, cause accelerated learning and 
increased GFAP levels (Elmore et al. 2014; Prinz, Erny, and Hagemeyer 2017). This 




are not completely understood, it is clear that direct manipulation of microglia alters the 
ability of neurons to wire and function normally.  
 
Figure 3. Microglia contribution to normal CNS functions. As resident immune cells in 
the CNS, microglia display many functions to maintain tissue homeostasis. Microglial cells 
modulate wiring and patterning during development by regulating neuron populations via 
phagocytosing excess synapses, releasing neurotrophic factors and guiding sprouting 
vessels. During postnatal development and adulhood microglia contribute to activity-
dependent circuit formation, maturation of neuronal networks, regulation of adult 






1.5. The role of microglia in brain inflammation and injury 
 
Besides contributing to the development and maintenance of the central nervous system, 
microglia function as the primary immune cells of the CNS. They provide the first line of 
defense against invading pathogens, and via the constant interaction with neurons, they often 
are the first to detect critical changes in neuronal activity and health status (Prinz & Mildner, 
2011). Upon detection of danger associated molecular patterns (DAMPs, ATP, heat shock 
proteins, DNA, HMGB1), released by stressed or injured neurons, microglia initiate a series 
of responses triggered by a plethora of surface receptors, such as Toll-like receptors (TLRs), 
purinergic receptors, scavenger receptors, and cytokine and chemokine receptors (Salter & 
Stevens, 2017). Their activation results in phagocytosis of pathogens and dying cells and the 
release of soluble factors involved in neuronal damage, tissue repair, and remodeling as well 
as recruitment of other immune cells from the blood (Stevens & Schafer, 2018). In recent 
years, multiple studies have indicated that microglia function as a double-edged sword, 
playing a protective or a detrimental role depending on the given conditions during different 
brain pathophysiologies (Shemer, Erny, Jung, & Prinz, 2015). Depending on the nature of 
the stimulus, microglia can take a number of activation states, which correspond to altered 
microglia morphology, gene expression, and function. For example, it has been reported that 
upon acute injury such as traumatic brain injury (TBI), early microglial responses may 
contribute to the restoration of brain homeostasis (Donat, Scott, Gentleman, & Sastre, 2017). 
Selective elimination of microglia was found to exacerbate brain injury after experimental 
stroke (Szalay et al., 2016). On the other hand, prolonged microglial activation or the release 
of pro-inflammatory cytokines (IL-1, IL-6, TNFa) and chemokines (CCL2, CX3CL1, MIP-
1), may result in augmented tissue damage and this may potentially contribute to 
neurodegeneration.  
 Uncontrolled synapse loss might indicate microglial dysfunction, which eventually can lead 
to reduced neuroprotection and neuronal repair, and increased neurodegeneration associated 
with chronic neuroinflammation (Salter & Stevens, 2017). For example, microglial 
dysfunction contributes to neurodegeneration in experimental models Alzheimer’s disease 
(AD) and Parkinson’s disease (PD) (Ransohoff, 2016). Selective elimination of microglia 
reduces cognitive deficits in experimental AD models (Najafi et al., 2018), which is similar 
to that seen after blockade of complement-mediated synapse elimination (Salter & Stevens, 
2017). Furthermore, large-scale genome-wide association studies (GWAS) have revealed 




microglial dysfunction is considered to be a primary disease mechanism, providing a direct 
link between microglia and neurodegeneration (Prinz et al. 2011; Arcuri et al. 2017). A good 
example is Nasu-Hakola disease, an autosomal recessive disorder characterized by 
progressive dementia and bone cystic lesions (Kaneko, Sano, Nakayama, & Amano, 2010), 
showing that microglia may act as a primary contributor to the disease. This rare genetic 
disease is caused by mutations in the DNAX activation protein 12 (DAP12) or triggering 
receptor expressed on myeloid cells 2 (TREM-2) in microglial cells (Paloneva et al., 2002), 
which results in impaired phagocytic activity and excessive pro-inflammatory microglial 
activation. Other studies have uncovered, that similar mutations on DAP12 and TREM-2 
could be strongly linked to the progression of AD and frontotemporal dementia (Salter and 
Stevens 2017; Kleinberger et al. 2017). Several other CNS disorders have been considered 
to be caused by genetic mutations resulting in microglial dysfunction, including Rett 
syndrome, Fragile X syndrome and Phelan-Mc Dermic syndrome (Arcuri et al., 2017). Thus, 
depending on their phenotype and role in given physiological processes, microglia may also 
play diverse roles in differrent brain diseases. Therefore, understanding the mechanisms 
through which microglia recognize and respond to injury or infection and interact with other 
cell types in the brain may lead to the identification of novel therapeutic targets. Among 
many brain conditions, infections induce strong microglial reaction and experimental models 
of infection are valuable to study microglial responses and function. 
 
 
1.6. Neurotropic viruses 
 
Neurotropic viruses, which are capable of infecting nerve cells, are among both DNA and 
RNA viruses of different families. Their infection inside the CNS leads to serious clinical 
syndromes of meningitis, encephalitis or meningoencephalitis. Despite the presence of the 
blood-brain barrier and blood-CSF barrier, as it was discussed in detail in previous chapters, 
viruses have evolved to find their way into the CNS (Miller, Schnell, & Rall, 2016). Three 
major routes of viral entry into the brain have been identified, as outlined in Figure 4.: direct 
infection of the cells that comprise the blood-brain barrier (BBB) and blood-cerebrospinal 
fluid barrier; infection of cells that are able to cross these barriers; and transneuronal 
migration across synapses from the peripheral nervous system (PNS) into the CNS 




Alternatively, neurotropic RNA viruses including poliovirus (PV), measles virus (MV), or 
some members of the Flavivirus family, like West-Nile virus infect endothelial or epithelial 
cells of the BBB and can act through the engagement of Toll-like receptor 3 (TLR3) to 
induce pro-inflammatory cytokines by circulating antigen presenting cells. As a result, BBB 
integrity becomes compromised by loosening its tight junctions, allowing viral particle 
migration into the brain tissue. Viruses may also passively access resident CNS cells by 
infecting lymphocytes or monocytes that can be transported across the blood-brain barrier. 
This strategy is often referred to as the ‘Trojan horse’ approach because viral particles are 
released once the blood-borne leukocytes gain access to the parenchyma. A classic example 
of this mode of invasion is provided by the human immunodeficiency virus type 1 (HIV-1): 
CD16+ monocytes, permissive for HIV-1, traffic across the BBB and release virions that 
can then infect CNS microglia (McGavern & Kang, 2011). The third mode of CNS entry is 
transneuronal migration, a strategy adopted by rabies virus (RABV) herpesviruses (HSVs), 
and pseudorabies virus (PRV). Intracellular trafficking in PNS neurons, which is necessary 
to shuttle cellular components to and from the synapse, can be commandeered to facilitate 
viral travel within and among synaptically connected neurons. The best-characterized 
examples of this type of spread are provided by herpesvirus family members such as Herpes 
simplex type 1 (HSV-1) and the closely related PRV (Koyuncu et al., 2013). After infection 
of epithelial cells in the oral mucosa, HSV-1 spreads to sensory and autonomic ganglia, 
establishing lifelong latency (Pomeranz, Reynolds, & Hengartner, 2005). Inside infected 
epithelial cells, these viruses become non-lytic within PNS neurons. During latency, only a 
few viral transcripts are synthesized, which do not encode functional proteins but prevent 
neuronal apoptosis via inhibition of caspase activity and disruption of both innate and 
adaptive immune signaling (Getts, Chastain, Terry, & Miller, 2013). However, in response 
to decreasing to immune monitoring, stress or other infections the virus can reactivate from 
its latent phase, which leads to an active infection of PNS neurons. Newly replicated viral 
particles can traffic along via microtubule tracks along the axons of sensory neurons, which 
have a pseudo-unipolar morphology. This way one axon is in contact with epithelial cells 
and the other synapses are in contact with CNS neurons (Kramer & Enquist, 2013). Such 
viral strains can reactivate long after the initial viral exposure, contributing to several 





Figure 4. Different routes of viral entry into the CNS. a, Direct infection of BBB 
endothelial cells, followed by release of viral particles into the parenchyma (left panel). 
Some viruses can diffuse across permeable regions of the BBB, by influencing the release 
of pro- and anti-inflammatory cytokines or various interferons (IFNß, IFNγ, IFNλ), which 
can loosen barrier integrity (middle panel). With the ’Trojan horse’ approach (right panel), 
viruses can infect lymphocytes, monocytes or macrophages which traffic across the BBB or 
blood-CSF barrier, releasing virus particles once in the brain parenchyma. b, Transsynaptic 
spread of viral particles involves the transport of viral genomes and associated proteins via 
microtubules and molecular motor proteins. Rabies virus (RABV) moves from muscle, 
across the neuromuscular juction via dinein-mediated retrograde transport into the CNS (left 
panel). Herpes simplex virus (HSV), Pseudorabies virus (PRV) and Varicella zooster virus 
(VZV) traffic across the endothelial-neuron junction. Inside neurons retrograde transport 
brings virions to the neuronal soma, and anterograde transport delivers them to the PNS-




1.6.1. Pseudorabies virus 
 
Pseudorabies virus (PRV) belongs to the same family, Alphaherpesviridae, as the human 
pathogen Herpes Simplex Virus (HSV) and Varicella Zoster Virus. The natural host of the 
virus is the pig, in which viral infection leads to Aujenszky’s disease (Schmidt, Hagemoser, 
& Kluge, 1992) with similar symptoms to that caused by rabies infection. PRV has a wide 
range of hosts, infecting all mammals except for higher primates (McFarland, Hill, & 
Tabatabai, 1987), probably due to circulating autoantibodies. Among other virus strains 
(vesicular somatitis virus, rabies virus, mouse hepatitis virus) pseudorabies virus have the 
unique ability to spread between exclusively synaptically connected chains of neurons. Such 
neuronal spread requires direct virus entry into the neuron (first-order neuron) and 
replication. The encapsulated viral genome is then transported at sites of synaptic contact to 
a second order of neuron where replication takes place again. This self-amplificating 
property allows the first order neuron as intensly labeled as the second or third order neurons 
(Pomeranz et al., 2005).  Tracing studies using this feature of  PRV have been successfully 
employed in a number of different animal models: pigs (the natural host), lambs and sheep, 
dogs, cats, chicken embryos, ferrets, and other rodents such as rats, mole rats, mice, gerbils, 
and hamsters (J. P. Card 1998; J. Card et al. 2018). Transsynaptic spread, self-amplification 
and broad host range made PRV an ideal tool in an extensive number of neuroanatomical 
studies seeking to define the architecture of multisynaptic pathways (Kramer & Enquist, 
2013). Transsynaptic spread of PRV was proved by detailed electron microscopic studies 
which support the view that PRV spreads in the CNS primarily by direct cell-cell contact, 
rather than diffusion of virions through the extracellular space or via non-neuronal cells. 
Analysis of infected nervous tissue by electron microscopy revealed viral capsids and 
structural proteins localised at the synapses of infected neurons (Pomeranz et al., 2005). This 
feature of the virus was well described via the analysis of different neuronal pathways 
between the ventral musculature of the stomach to the brainstem and higher order structures 
of the CNS (Pomeranz et al., 2005). PRV spread in the nervous system also requires 
synaptically connected intact neuronal circuit. This was tested by direct injection of  PRV 
into brain ventricles, which result only in the infection of nearby neurons, astrocytes and 
ependymal cells which line the walls of ventricles, but the virus did not spread futher 
(Rinaman, Card, & Enquist, 1993). Even tough, PRV is able to infect non-neuronal cells in 
the brain, such as epitehelial cells and astrocytes, non-synaptic spread is severly limited. 




not contribute to trans-neuronal spread of the virus (Card, J. P., 2001). Rather, the infection 
of astroglia is tought to represent an effort of local intrinsic and innate immune defense to 
contain the infection (Card, J. et al., 2018). According to previous studies, microglial cells 
are the only cell type which can not be affected by PRV, althoug the exact reason is still 
unclear (Rinaman et al., 1993). When injected directly into the brain parenchyma, PRV 
virions diffuse very little, producing only focal infection site (Pomeranz et al., 2005). In 
order to effectively infect neurons, replicate and produce infectious progeny, and spread 
through synapses the virus needs several essential elements, including envelope proteins, 
which help viral capsids to interact with the extracellular matrix and gain access to 
permissive neurons (Figure 5.a,). PRV uses a common adhesion molecule, nectin to invade 
neurons through a receptor-mediated fusion of the viral envelope and plasma membrane of 
the target cell (Brittle, Reynolds, & Enquist, 2004). As a result, tegument protein associated 
viral capsids, containing the genome are released inside the host neuron, where they are 
transported along microtubules to the soma. The genome of virus enters the nucleus along 
with tegument proteins which initiate the expression of immediate early genes and initiates 
a transcription cascade which generates all necessary proteins for new virions (Brittle et al., 
2004). During the lytic cycle viral genes (immediate-early, early and late) are expressed in 
a certain timeline. After achieving the right amount of copies, virus DNA is packed into 
capsids and exit the nucleus. Before leaving the host cell, naked capsids require 
envelopment, then they get transported into vesicles (Figure 5. c,) (Koyuncu et al., 2013). 
 The attenuated vaccine strain of PRV (PRV-Bartha) which have reduced virulence has been 
successfully used as a self-amplifying neural tracer after peripheral injection for its reduced 
neurotoxicity and prominently retrograde spread. Mutant PRV-Bartha strains are favored for 
tracing studies because they penetrate further into neuronal circuits due to increased host 
survival time. Since Bartha strains lack glicoprotein E, once introduced into the nervous 
system, PRV-Bartha spreads only in retrograde direction inside a circuit, while wild type 
strains, such as PRV-Becker and PRV-Kaplan, spread in both anterograde and retrograde 
directions (Pomeranz et al., 2005). Since Bartha strain is able to infect PNS neurons 
projecting to CNS neurons and invade specific brain regions by retrograde transport, the 
strain has been widely used for defining CNS ciruits that modulate the autonominc and 
somatic peripheral outflows (Pomeranz et al., 2005). The detailed retrograde spreading of 
PRV-Bartha has been effectively characterized in rats and hamsters, by injecting the virus 
intraocularly (Card, J. P., 1998).  As different genetically modified PRV-Bartha strains have 




further enhance this powerful tool. Major autononmic pathways were defined during stress 
situations via dual tracing, employing ß-galactosidase (product of lacZ) expressing PRV-
Bartha strain kombined with PRV-Kaplan strain (Jansen, Van Nguyen, Karpitskiy, 
Mettenleiter, & Loewy, 1995). Since then this dual tracing approach was used to map 
multiple autonomic connections in the CNS. Besides ß-galactosidase enzime, different 
fluorophores were inserted into PRV derivatives as well, such as EGFP or DSRed. In a model 
of cultured rat dorsal root ganglia the same fluorescent strains were used to uncover 
collateralized pathways (Miranda-Saksena, Boadle, Armati, & Cunningham, 2002). 
Genetically modified viral tracers, such as PRV, HSV or rabies only recently started to 
become powerful tools to study viral infections and immune responses in the CNS.  
 
 
Figure 5. Structure and spreading mechanism of Pseudorabies virus. a, The structure of 
alphaherpes virus virions compose of several capsid and tegument proteins that are contained 
within the virus envelope which is acquired from the host cell. The envelope contains a 
second set of virally encoded proteins that are crucial for target recognition, attachment and 
fusion that lead to the release of the capsid into permissive neurons. b, Mutant strains of 
PRV spread selectively in the retrograde direction through exclusively synaptically linked 
neural circuits. c, Multiplication of virions is a multistep process which lead to assembly of 
mature virions in the cell soma. Virions are trafficked through the soma and denrites of 
infected neurons by vesicular motor proteins and released in the vicinity of synapses 




1.7. Infection-induced inflammation and anti-viral immunity in the brain 
 
Invasion of pathogens, such as viruses, bacteria or parasites into the brain results in chronic, 
often lethal diseases, which are associated with severe blood-brain injury, impaired neuronal 
communication, innate myeloid cell activation, and leukocyte infiltration. Unlike other cell 
types of the CNS, neurons are generally non-renewable, thus the cytolytic and inflammatory 
strategies that are effective in the periphery could be damaging if deployed in the brain (Getts 
et al., 2013). Upon infection-induced inflammation, the immune response of the brain aims 
to maintain neuronal network integrity while eliminate invading pathogens and the 
terminally injured cells.  
As discussed above, the brain is shielded from external threats at both macro- and 
microscopic levels: it is enveloped in bone, to prevent physical injury, and separated from 
peripheral tissues and blood via highly specialized barriers. To overcome this, viruses have 
developed sophisticated strategies to enter the CNS either via transcellular and paracellular 
pathways across the BBB or anterograde/ retrograde trafficking along neurites from 
peripheral neurons (Miller et al., 2016). If occurring via parenchymal routes, pathogen 
invasion into the brain is sensed immediately by specialized innate immune cells, which 
include microglia, perivascular macrophages, and meningeal or choroid plexus 
macrophages. As first responders to tissue injury and pathogen invasion, brain myeloid cells 
are equipped to launch an immune response (Prinz et al., 2011).  In case the reaction of CNS 
cells to infection or tissue injury extend a certain limit, vascular activation and production 
of chemokines may initiate the recruitment of immune cells from the periphery. Thus, 
regulation of the central immune response is crucial in protecting the brain from further 
tissue damage due to immunopathology, and lingering inflammation that can sometimes 
augment BBB injury, neuronal loss and hinder the tissue repair process (Russo & McGavern, 
2015).   
Although immune cell migration into the CNS is tightly regulated due to the blood-brain 
barrier (BBB), several routes exist for peripheral leukocytes to enter the CSF, the choroid 
plexus (CP), the meninges, perivascular spaces and eventually the parenchymal tissue (Prinz 
et al., 2017). Following infection by different neurotropic viruses, both innate (monocytes, 
neutrophil granulocytes) and adaptive immune cells (CD8+ T cells, CD4+ T cells and B cells) 
are recruited, to participate in pathogen elimination and clearance. Upon pathogen entry into 
the CNS, most immune responses begin with pattern recognition receptors (PRRs) sensing 




(RLRs), or Nod-like receptors (NLRs) expressed by neurons, astrocytes, and microglia 
(Klein & Hunter, 2017). At the BBB, in response to TLR and PRR activation endothelial 
cells and astrocytes become strongly activated, and try to control viral entry (Rinaman et al., 
1993). Endothelial cells respond to these cues via modulating barrier integrity through 
altered expression of CAMs and Rho GTPases, while activated astrocytes produce 
proinflammatory cytokines such as Il-1, IL-6, TNFa, and IFNγ. These proinflammatory 
cytokines aid in viral clearance through recruitment of mononuclear cells but may also be 
detrimental long-term to neuronal function and regeneration. Among the infiltrating immune 
cells,  T cells are the first to enter the CNS during viral infection, with the production of T 
cell-derived cytokines, such as IFN-γ, which is critically involved in viral clearance and the 
amplification of immune cell infiltration through upregulation of chemokines. Recent 
studies have highlighted the importance of T cell recruitment and their reactivation in 
multiple infection models. In an HSV-1 induced encephalitis model inhibition of  T cells via 
the downregulation of CXCL9 T cell attractant chemokine lead to increased mortality during 
HSV-1 infection. Direct injection of CXCL9 into the CNS infection site enhanced HSV-1 
specific CD8+ T cell accumulation, leading to marked improvements in the survival of 
infected mice (Koyanagi et al., 2017). In a clinical study of blood donors testing positive for 
West-Nile virus (WNV), T regs were found to expand after infection, and asymptomatic 
patients had higher levels of T reg cells compared to symptomatic patients, suggesting that 
T regulatory cells (T regs) control of antiviral responses may influence the severity of clinical 
disease. Similar results could be detected in a mouse WNV infection model, in which 
animals depleted of T regs showed more severe symptoms and had significantly higher 
mortality rate than control mice (Lanteri et al., 2009). Importantly, the specific chemokine 
milieu in the infected brain appears to influence T cell activity and antiviral response as well. 
Cytokines expressed by T cells, also have a major role in the antiviral response, such as IFN-
γ which control infectious virus replication in the periphery but clears the virus from the 
CNS, without affecting acute viral replication (Baxter VK. et al., 2016). Animals that lack 
IFN-γ or the ability to signal through its receptor IFNγR, exhibit decreased B cell recruitment 
(Klein & Hunter, 2017). B cell functions, including antiviral humoral immune responses, are 
critical for control of viral dissemination in the periphery and neuroinvasion during 
neurotropic viral infections (reviewed in (Kyle Austin & Dowd, 2014). Early infiltrating B 
cells express multiple cytokines (such, as CXCL9, CXCL10, CCL19) which are upregulated 
within the CNS during viral infections. Although classically considered part of the adaptive 




generation of specific immunoglobulin G (IgG) (Rojas, Narváez, Greenberg, Angel, & 
Franco, 2008).  B cell responses to viruses are often initiated antigen recognition via their 
surface immunoglobulin receptors, such as IgG and IgM. Their activation and proliferation 
are also affected by T cell chemokine expression, although a recent study of neurotropic 
coronavirus infection suggest that activated B cells can respond to viral infection 
independently from CD8+ T cells (Phares, Marques, Stohlman, Hinton, & Bergmann, 2011). 
Their crucial role in viral infection was also proved by an infection model induced by the 
neurotropic strain JHMV of mouse hepatitis virus, in which the absence of B cells resulted 
in uncontrolled, persistent CNS infection despite viral reduction by T cells (Phares et al., 
2011). As described above, PRR detection of viral nucleic acids induces expression of 
chemoattractants that promote the parenchymal entry of mononuclear cells, including blood-
borne monocytes, which differentiate into tissue macrophages at sites of infection or injury. 
Upon neurotropic viral infections, it is still an uncleared question whether these cells aid in 
viral clearance and recovery or mediate continuing damaging inflammation in the CNS 
(Klein et al. 2019.). Macrophages can produce anti-inflammatory mediators, scavenge the 
infected area, phagocytose cell debris and regulate extracellular matrix and glial scar 
surrounding the damaged area (London, Cohen, & Schwartz, 2013). However, these cells 
have also been shown to have potent effector functions, including antigen presentation, T 
cell stimulation, and production of multiple proinflammatory mediators and reactive oxygen 
species (Terry et al., 2012). Monocyte recruitment can be affected by depletion of CCL2 and 
CCL7 proinflammatory cytokines resulting in increased viral burden and mortality (Bardina 
et al., 2015). Upon subsequent restoration of CCL7 by exogenous administration increased 
monocyte and neutrophil recruitment and improved survival.  
Microglia are thought to protect CNS from viral infection via multiple mechanisms, 
including the production of antiviral cytokines, phagocytosis of virus-infected and dying 
neurons, and the induction of neuronal repair and homeostasis (Prinz et al. 2011; Ransohoff 
and Engelhardt 2012). In addition to restricting viral replication, microglia are suggested to 
orchestrate peripheral immune response against invading pathogens in the CNS.  In the 
healthy brain, microglia do not express MHC, however, when activated by pathological 
conditions, they upregulate these molecules (Tsai et al., 2016).  However, assessing specific 
immune contributions of microglia during infections has been challenging for multiple 





1.8. The role of microglia in neurotrop viral infections of the CNS 
 
As the main resident immune cell type of the brain parenchyma, microglia are known to 
shape CNS immune responses to viral infections that occur in the brain. However, for 
multiple reasons, the functional contribution of microglia to neurotropic viral infections has 
been described inadequately. Previous studies have stated, that microglia coordinate CNS 
immune responses via pro-inflammatory cytokine or chemokine secretion, and possibly via 
presenting antigen to T cells that are recruited into the brain (Zhang, Liu, & Wei, 2017). In 
response to a pathogen invasion microglia increase the expression of toll-like receptors 
(TLRs) which are critical in generating innate immune reactions. Others have indicated that 
in the case of HSV infection microglial TLR2 and TLR9 signaling have a pivotal role in the 
production of proinflammatory cytokines and chemokines (J. Card et al. 2018; Rinaman, 
Card, and Enquist 1993). As an anti-viral response, IFN-I production by microglia and 
phagocytosis of infected cells have been previously observed (Dénes, Boldogkoi, Hornyák, 
Palkovits, & Kovács, 2006). Rapid induction of microglia was also noticed in response to 
the immediate release of normally intracellular proteins and/or high-energy purine 
nucleotides (such as ATP, ADP, and UTP) from injured neurons (Davalos et al., 2005a). As 
it was previously described by others (Wolf, Boddeke, and Kettenmann 2017; Davalos et al. 
2005) massive release of purines occurs after metabolic stress or trauma that might trigger 
microglial activation through P2 type receptor-mediated mechanisms (Dénes et al., 2006). 
However, it remains unknown if these mechanisms are involved in the activation and 
recruitment of microglia during virus infections. In spite of this information, studying 
microglial responses during viral infections in vivo has been quite difficult. As previous 
studies have described (J. P. Card 2001; Boldogköi et al. 2004; Dénes et al. 2006), it is clear 
that PRV and HSV infection of the brain produces a complex cascade of innate responses 
that are not limited to microglia (Rinaman et al., 1993). Virulent and attenuated strains of 
HSV and PRV have been shown to induce neuropathological changes and ultimately lead to 
reactive astrogliosis, activation and recruitment of brain macrophages and different CD45-
positive blood-born immune cell populations to sites of infection (Dénes et al., 2006).  Using 
the more virulent Becker strain of PRV, trafficking, and appearance of cells positive for 
CD45 leukocyte common antigen as well as CD8+ cytotoxic- and CD4+ lymphocytes at the 
sites of infections were reported. However, activated microglia also express CD45, therefore 
the distinction between infiltrated CD45-positive leukocytes and resident microglia 




Note, that in this complex inflammatory cascade it has been very difficult to isolate 
immediate microglial immune responses. Discrimination of microglia from infiltrated 
monocytes and macrophages is difficult due to the phenotypic transformation of activated 
microglia rendering them morphologically similar to infiltrating mononuclear phagocytic 
cells. According to previous researches (Rassnick et al. 1998; Enquist and Leib 2016) it is 
becoming increasingly clear that multiple glial cells participate in the immune response to 
neurotropic viral infections by isolating afflicted neurons and thereby facilitating 
transsynaptic spread of the virus (Rinaman, Card, and Enquist 1993; Boldogköi et al. 2004). 
Previous research proved that highly GFAP-positive astrocytes have the ability to isolate 
infected neurons, by wrapping afflicted cells and their synaptic contacts with processes that 
separate them from uninfected cells (Rinaman et al., 1993). Also, TLR3 was shown in 
astrocytes to sense HSV-2 infection immediately after entry into the CNS, possibly 
preventing HSV from spreading beyond the neurons mediating entry into the CNS (Reinert 
et al., 2012). However, it is likely that astrocytes do not have the ability to phagocytose 
compromised neurons, unlike microglia and macrophages. By using genetically modified 
strains of the „Bartha-Dup” strains of PRV (Boldogköi et al., 2004). Dénes et al., 2006 have 
described, that microglia are able to respond rapidly to early infection and isolate 
compromised neurons even while the infected neuronal membrane is still intact. Even though 
the exact molecular mechanisms of microglial responses to early infection need to be further 
investigated. By using the same highly specific, retrograde, transsynaptically spreading 
„Bartha-Dup” PRV strain and highly selective microglia elimination tool we were able to 







Microglia are the main immunocompetent cell type of the CNS that play a role in multiple 
physiological and pathological processes. The importance of microglial actions in acute 
brain injury, such as brain trauma or stroke and in chronic neurodegenerative diseases, like 
Alzheimer’s is widely recognised. However, the role of microglia in anti-viral immunity of 
the brain is less studied. Notably, the mechanisms through which microglia recognize signs 
of infection at the cellular level and how infected cells are discriminated are still unclear. 
Therefore, the main goal of my work was to investigate inflammatory processes in the central 
nervous system during neurotropic virus infection, focusing on the following three main 
topics: 
 
1)  To study central inflammatory processes and the functional role of microglia in a 
mouse model of neurotropic virus infection.  
2) To identify the role of microglial P2Y12 receptor in neurotropic virus infection. 
3) To study inflammation and microglial responses in human post-mortem brain tissues 







3. Materials and methods 
 
3.1. Processing of human samples 
 
Post-mortem human brain tissues 
Formalin fixed, paraffin embedded (FFPE) post-mortem tissue sections from patients (n=5) 
with known HSV-encephalitis (age between 42-66 years) were used. Tissue samples from 
two additional patients with no known neurological disease were used as controls. Control 
samples were perfusion-fixed with Zamboni fixative (4% PFA, 15 % PIC) and postfixed 
overnight in the same solution. All performed procedures were approved by the Regional 
and Institutional Committe of Science and Research Ethics of the Scientific Council of 
Health (ETT-TUKEB 62031/2015/EKU, 34/2016 and 31443/20116EKU (518/pi/11)).  
 
Immunohistochemistry and immunofluorescence on post-mortem human brain tissues 
To investigate microglia recruitment in response to neurotropic virus infection in the human 
brain, 4-6µm thick brain sections were cut and samples were mounted on gelatine-coated 
slides. After deparaffination, HIER (Novocastra Epitope Retrieval Solution pH9, Leica 
Biosystems) and peroxidase blocking (in 1% H2O2 solution) was carried out. Sections were 
blocked with 2.5% Normal Horse serum (#S-2012, Vector Laboratories) and were incubated 
with microglia and immune cell specific primary antibodies, see in Table 1. For signal 
amplification ImmPRESS anti-rabbit HRP Kit (#MP-7401, Vector Laboratories) and for 
visualisation either ImmPACT NovaRED HRP substrate (for detection of HSV I) or DAB-
Ni HRP substrate (for detection of other markers, #SK-4805, Vector Laboratories) was used. 
Representative pictures were taken on 20x magnification using a Nikon Ni-E C2+ 
microscope. To assess the proportion of P2Y12-positive microglia, P2Y12 and Iba1 double 
immunofluorescence has been performed on 50 µm thick free-floating brain sections. Images 
were captured using a Nikon Eclipse Ti-E inverted microscope (Nikon Instruments Europe 
B.V., Amsterdam, The Netherlands), with a CFI Plan Apochromat VC 60X water immersion 






Table 1. All primary antibodies used for human microglia and infiltrated immune cell 
labeling. 
 
Antigen Host species Target species Dilution Catalogue number 
HSV I rabbit human 1:200 #361A-14, Cell Marque 
HSV II rabbit human 1:200 #362A-14, Cell Marque 
P2Y12 rabbit human 1:100 #AS-55043A, AnaSpec, 
Inc. 
Tmem119 rabbit human 1:250 #ab185333, Abcam 
CD68 mouse human 1:50 #NCL-L-CD68, Leica 
CD45 mouse human 1:50 #NCL-L-LCA_1 ml, 
Leica 
CD3 mouse human 1:100 #NCL-L-CD3-565, 
Leica 
CD20 mouse human 1:100 #NCL-L-CD20-L26, 
Leica 





Table 2. Patient characteristics and tissue processing information for post-mortem human brain tissues. 
 
















none bronchopneumonia <24 h 8 weeks 
 2 66 female 16 days temporal 
lobe 
none acute encephalitis/ 
brain/ 
edema/herniation 
<24 h 8 weeks 
 3 65 female 9 day temporal 
lobe 
none acute encephalitis/ 
brain/ 
edema/herniation 
<24 h 3 weeks 




none bronchopneumonia <24 h 4 weeks 
 5 24 male 10 days temporal 
lobe 
none acute encephalitis/ 
brain/ 
edema/herniation 
62 h 3 weeks 























3.2. In vivo mouse expreiments 
 
Animal housing and treatment 
Experiments were carried out on 12-18 weeks old C57BL/6J, P2Y12-/-, P2X7-/-, 
Cx3Cr1GFP/+ and Cx3Cr1GFP/+ P2Y12-/- mice. Mice were maintained at 12 h light/dark 
cycle with food and water avaliable ad libitum in the Medical Gene Technology Unit of 
the IEM. All experimental procedures were performed according to the ethical guidelines 
set by the European Communities Council Directive (86/609 EEC) and the Hungarian 
Act of Animal Care and Experimentation (1998; XXVIII, Sect. 243/1998), approved by 
the Animal Care and Use Committee of the Institute of Experimental Medicine of the 
Hungarian Academy of Sciences. 
Selective elimination of microglia in the brain 
Mice were fed a chow diet containing the CSF1R-inhibitor PLX5622 (Plexxikon Inc. 
Berkeley, USA; 1200 mg PLX5622 in 1 kg chow) for three weeks to eliminate microglia 
from the brain. We could not observe any sign of physiological illness (alterations in food 
intake, weight, physical appearance) or behavioural changes (social interactions, 
exploration) during the diet period, in accordance with other studies (Szalay et al., 2016). 
Neurotropic herpesvirus infection 
For all experiments genetically modified  recombinant strains of PRV-Bartha derivatives, 
PRV-Bartha-Dup-Green (BDG) or a parent viral strain expressing red fluorescent protein, 
PRV-Bartha-DupDsRed (BDR) were used (Boldogköi et al., 2002). To study the 
recruitment of microglia to infected neurons, we used the ability of the virus to induce 
retrograde transsynaptic infection in the brain after injected into peripheral target organs 
(Card, J. P., 2001). The neuro-invasiveness of BDG was modified by insertion of a GFP 
gene expression cassette to the putative antisense promoter (ASP) located at the repeated 
invert region of the virus. This construct also allows time-mapping the spread of infection 
in individual cells (Boldogköi et al., 2004). The activity of the strong immediate-early 
promoter/enhancer of the human cytomegalovirus is independent from the viral protein, 
enabling very early stages of infection to be detected by GFP expression. PRV genes 
encoding structural proteins are driven by late promoters, resulting in the appearance of 
the virus proteins in the late stage of the infection. Mice were injected either 
intraperitoneally or directly into the epididimal adipose white tissue. In a series of studies, 




injected on 16th day of the diet to assess the effect of the infection whitin microglia 
depleted environment (see Fig2. c,). For in vivo two-photon imaging, Cx3Cr1+/GFP mice 
were infected with BDR, allowing us to examine viral infection and microglial actions at 
the same time. After the viral injection, we allowed mice to survive for 5-7 days 
depending on the study design and regularly monitored them for neuropathological 
symptomes and behavioral changes.   
 
In vivo two-photon imaging 
Virus injection and cranial window surgery: To assess microglia recruitment to infected 
neurons in the mouse brain in real-time, Cx3Cr1GFP/+ mice were i.p. injected with 10μl of 
the BDR virus (1,5x1010 PFU/ml). 7 days after virus injection, cranial window surgery 
was performed on anaesthetized (3% isoflurane for induction, 1.5-2% during surgery) 
mice and a circular craniotomy (3 mm diameter) was made above motor cortex (Bregma 
– 0,82); on the right hemisphere. A custom-made aluminium head plate was fixed to the 
skull using Cyanoacrylate glue. During skull opening the place of craniotomy was washed 
continuously with cold Ringer solution. The craniotomy was covered with a circular 
cover glass and dura mater remained intact under the glass to ensure that microglial 
activation is not induced by the surgical procedure (Szalay et al., 2016). The cover glass 
was fixed with Paladur mixed with Cyanoacrylate.  
 
Two-photon imaging: Measurements were performed by using a Femto2D-
DualScanhead microscope (Femtonics Ltd., Hungary) coupled with a Chameleon Ultra 
II laser (Coherent, Santa Clara, USA) (Chiovini et al., 2014). The wavelength of the laser 
was set to 980nm to measure DsRed and GFP signal simultaneously. Excitation was 
delivered to the sample, and the fluorescent signal was collected using a CFI75 LWD 
16XW/0.8 lens (Nikon, 16x, NA 0.8) and then separated using a dichroic mirror 
(700dcxru) before the two channel detector unit, which was sitting on the objective arm 
(travelling detector system) as described in detail earlier (Katona et al., 2012). The 
dichroic mirror and emission filters (490-550 nm for the green and 570-640 nm for the 
red channel) was purchased from Chroma Technology Corp. (Vermont, USA). Data 
acquisition was performed by MES softver (Femtonics Ltd.) A Z-stack from of 32 images 




µm step size (range= 80-135 µm from pial surface) was made at every 3 minutes. Two-
photon image sequences were exported from MES and analysed using ImageJ.  
 
Tissue processing and immunostaining on mouse brain samples 
Under deep anaesthesia with intraperitoneal injection with Fentanyl (0.25 mg/kg) mice 
were transcardially perfused with 0.9% saline for 2 minutes, followed by 4% 
paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, Ph= 7.4) for 20 minutes. After 
fixation, the brains were carefully removed from the skull, and were postfixed in 10% 
sucrose 4% PFA solution for 24 hour. After that the solution was changed to 10% sucrose 
PBS for cryoprotection and to remove the fixative. The brains were then sectioned at 25 
µm thickness using a Leica sledge microtome (Leica Biosystems). Free-floating brain 
sections were used for immunostaining throughout the study. Brain sections were blocked 
with 2% normal donkey serum and incubated with a mixture of primary antibodies in 
Table 3. overnight at 4oC. The following day after several washing steps all slices were 
labelled with the appropriate fluorescent secondary antibodies (Table 3.). Images were 
captured with a Nikon Ni-E C2+ confocal microscope, and image processing was done 
using the NIS Elements Viewer 4.20 software. Quantitative analysis was performed on 3 
randomly selected fields within the region of interest for each brain section, on 3-3 serial 
coronal sections for given brain areas.   
 
Immunohistochemical labeling for NTPDase1 
After the fixative was washed out, the coronal brain sections were incubated in blocking 
solution (5% normal goat serum and 1 mg/ml BSA) for 1 h at 22 ˚C. Incubation in the 
solution of the polyclonal NTPDase1 antibody, was performed overnight at 4 oC. 
Following three, 10 min washes in PBS, the sections were incubated with biotinylated 
secondary antibody for 2 h. The staining was performed with Vectastain ABC Elite kit 
using DAB as the chromogen. After washing thoroughly with distilled water, sections 
were postfixed in 1% OsO4, dehydrated in ethanol, stained with 1% uranyl acetate in 50% 
ethanol for 30 min, and embedded in Taab 812. Negative control experiments were 
performed using the same protocol but substituting pre-immune serum for the primary 
antibody. Ultrathin sections were cut using a Leica UCT ultramicrotome (Leica 
Microsystems, Milton Keynes, UK) and examined using a Hitachi 7100 transmission 





Table 3. Primary and secondary antibodies used in this study. 
Antigen Host species Target species Dilution Catalogue number Secondary anibodies 
Iba1 donkey goat 1:500 #NB100-1028, Novusbio 
 
donkey-anti-goat Alexa594 
P2Y12 rabbit mouse 1:500 #55043A, Anaspec 
 
donkey anti-rabbit Alexa647 
CD45 rat mouse 1:250 #MCA1388, AbD Serotec 
 
doneky anti-rat Alexa594 
anti-PRV rabbit PRV 1:500 custom made 
(from Lynn Enquist) 
donkey anti-rabbit Alexa647 
anti-GFP donkey chicken 1:1000 #A10262, Invitrogen 
 
donkey anti-chicken Alexa488 
CD68 rat mouse 1:250 #NCL-L-CD68, Leica 
 
donkey anti-rat Alexa594 
tomato lectin biotinylated ------------- 1:100 #L0651-1MG, Sigma 
 
steptavidin Marina Blue 
ICAM donkey goat 1:500 #AF796, R&D Systems 
 
donkey anti-goat Alexa594 
NDTPase rabbit donkey 1:500 custom made 
(from Jean Sévigny) 
donkey anti-rabbit Alexa647 






Fixation of the tissues: The brains were fixed by the standard protocol. . Following fixation, 
phosphate buffer (PB) was perfused to remove extra fixative from the tissue. Brains were 
removed from the skull and 50 µm thick free-floating sections prepared by using a Leica 
vibrotome (Leica Biosystems).  
Immunohistochemistry: Brain sections were incubated in 30% sucrose overnight for 
cryoprtection. To unmask antigens in the tissue and help the penetration of the antibodies, 
slices were frozen in liquid nitrogen 3 times and then washed in TBS buffer. After combined 
immunogold-immunoperoxidase stainings, sections were treated with osmium tetroxide, 
dehydrated in ascending ethanol series and acetonitrile, and embedded in epoxy resin. During 
dehydration, sections, were treated with uranyl acetate. After polymerization, 70 nm thick 
sections were cut on an ultramicrotome, picked up on formvar-coated single-slot copper grids, 
and sections were examined using a Hitachi H-7100 electron microscope.  
 
Correlated confocal laser-scanning microscopy, electron microscopy and electron 
tomography 
Fluorescent labeling for confocal microscopy: Before immunofluorescent labeling 50 µm 
thick brain sections from BDG-injected Cx3Cr1+/GFP mice were washed in PB, treated with 
0,5 % sodiumborohydride for 5 minutes, and further washed in PB and TBS. This was 
followed by blocking for 1 hour in 1% human serum albumin (HSA). After this, sections were 
incubated in mixtures of primary antibodies: chicken anti-GFP, rat-anti-mouse CD68 and 
rabbit anti-PRV. To eliminate non-specific binding, the anti-PRV antibody solution was 
incubated with control brain sections for one day before use. After repeated washes in TBS, 
sections were treated with blocking solution containing 0.5% cold water fish skin gelatine and 
0.5% HSA in TBS for 1 h. After incubation, sections were washed in TBS, and incubated 
overnight at 4 °C in the mixture of biotinylated goat-anti-chicken, Alexa 594 conjugated 
donkey-anti-rat and Alexa 647 conjugated donkey-anti-rabbit diluted in GelB. Secondary 
antibody incubation was followed by washes in TBS and PB. Sections were mounted in PB, 
coverslipped and coverslips sealed with nailpolish. Immunofluorescence was analysed using 
a Nikon Eclipse Ti-E inverted microscope (Nikon Instruments Europe B.V., Amsterdam, The 




an A1R laser confocal system. We used 488, 561 and 642 nm lasers, and scanning was done 
in line serial mode. Image stacks were obtained with NIS-Elements AR software with a pixel 
size of 50x50 nm in X-Y, and 150 nm Z-steps. Stacks were deconvolved using Huygens 
Professional software (www.svi.nl), and 3D-reconstruction was performed using the IMOD 
software package. 
Electron microscopy: After imaging, sections were washed 0.1 M PB, TBS and incubated in 
ABC (1:300, Vectastain Elite ABC HRP Kit, #PK-6100. Vector Laboratories) diluted in TBS. 
Sections were washed in TBS, and tris-buffer (TB) pH 7.6, and the immunoperoxidase 
reaction was developed using 3,3-diaminobenzidine as chromogen. After subsequent washes, 
sections were treated with 0.5 % osmiumtetroxide in PB for 20 minutes. Then sections were 
dehydrated in ascending ethanol series and acetonitrile, and embedded in epoxy resin. During 
dehydration sections were treated with 1% uranylacetate in 70% ethanol for 20 minutes. After 
polymerization, 70 or 150 nm thick sections were cut on an ultramicrotome, and picked up on 
formvar-coated single-slot copper grids. The sections were examined using a Hitachi H-7100 
electron microscope and a side-mounted Veleta CCD camera. 
Electron tomography: For the electron tomographic investigation, we used the 150 nm thick 
sections. Grids were put on drops of 10% HSA in TBS for 10 minutes, dipped in distilled 
water (DW), put on drops of 10 nm gold conjugated Protein-A (#AC-10-05-05, 
Cytodiagnostics) in DW (1:3), and washed in DW. Finally, we deposited 5-5 nm thick layers 
of carbon on both sides of the grids. Electron tomography was performed using a Tecnai T12 
BioTwin electron microscope equipped with a computer-controlled precision stage and an 
Eagle™ 2k CCD 4 megapixel TEM CCD camera. Acquisition was controlled via the 
Xplore3D software (FEI). Regions of interest were pre-illuminated for 4-6 minutes to prevent 
further shrinkage. Tilt series were collected at 2 degree increment steps between -65 and +65 
degrees at 120 kV acceleration voltage and 23000x magnification with -1.6 – -2 µm objective 
lens defocus. Reconstruction was performed using the IMOD software package. Isotropic 
voxel size was 0.49 nm in the reconstructed volumes. Segmentation has been performed on 





Super-resolution (STORM) microscopy 
 Free-floating brain sections were blocked with 2% normal donkey serum followed by 
immunostaining with rabbit anti-mouse P2Y12 antibody for microglia, donkey anti-chicken 
GFP for viral immediate-early GFP signal, and rabbit anti-PRV for virus protein labeling were 
used. For secondary antibody labelings donkey anti-rabbit Alexa 647, donkey anti-chicken 
Alexa 488 were used (in dilution described in Table2.). Sections were mounted onto 1.5 thick 
borocilicate coverslips and covered with imaging medium immediately before imaging. 
 
3.3. In vitro mouse experiments 
 
Primary cell cultures 
Neuronal cultures: Primary cultures of embryonic cortical cells were prepared from CD1 
mice on embryonic day 16 (Czöndör et al., 2009) . Cells were seeded onto poly-L-lysine–
coated (#P1524, Sigma-Aldrich) 24-well tissue culture plates at 3×105 cells/well density and 
grown in NeuroBasal medium (#21103-049, ThermoFisher Scientific) supplemented with 5% 
foetal bovine serum (FBS, #F7524, Sigma), B27 (#17504-044, ThermoFisher Scientific), 
Glutamax (#35050061, ThermoFisher Scientific), gentamicin (40 μg/ml, Sandoz), 
amphotericin B (2.5 μg/ml, #A2411, Sigma-Aldrich). Cytosine-arabinofuranoside (CAR, 5 
μM, #C6645, Sigma-Aldrich) was added to the cultures 48-72 h after plating to limit glia 
growth, and then one third of the culture medium was changed to NeuroBasal medium 
supplemented with B27 without FBS every 3–4 day thereafter. Cells were cultivated for 6-8 
days at 37°C in 5% CO2, 95% air atmosphere until further measurements.  
Astroglia and microglia cultures: Astroglia/microglia mixed cell cultures were prepared from 
the whole brains of CD1, C57BL/6J, CX3CR1GFP/+, P2X7-/- or P2Y12-/- newborn (P0-P1) 
mouse pups, as described earlier (Környei et al., 2005). In brief, meninges were removed and 
the tissue pieces were subjected to enzymatic dissociation, using 0.05% w/v trypsin (#T4549, 
Sigma Aldrich) and 0.05% w/v DNase (#DN-25, Sigma-Aldrich) for 10 minutes at room 
temperature. The cells were plated onto poly-L-lysine (#P1524, Sigma-Aldrich) coated plastic 
surfaces and were grown in Minimal Essential Medium (#M2279, Sigma-Aldrich) 
supplemented with 10% FBS (#10500, Gibco), 4 mM glutamine (#G3126, Sigma-Aldrich), 
40 μg/ml gentamycin (Sandoz) and amphotericin B (2.5 μg/ml, #A2411, Sigma-Aldrich) in 
humidified air atmosphere containing 5% CO2, at 37oC. The culture medium was changed on 




harvested by trypsinization and re-plated onto PLL coated glass coverslips or into petri dishes, 
according to the actual experimental design. Secondary astrocytic cultures reaching 
confluency and displaying mosaic-like pattern were infected with PRV strains, as it follows. 
Microglial cells were isolated from 21-28 day old mixed cultures either by shaking or by mild 
trypsinization (Saura, Tusell, & Serratosa, 2003).  
 
Neurotropic herpesvirus infection of primary neuronal and astroglial cultures 
The neuronal or astroglia cultures were infected with either PRV-Bartha-Dup-Green (BDG) 
virus or PRV-Bartha-DupLac (BDL) at a final titter of 2.5x105 PFU/ml, as described earlier 
(Gönci et al., 2010b). The multiplicity of infection (MOI) was ~0,17 PFU/cell. The cells were 
incubated with the virus containing medium for 1h, at room temperature. In order to remove 
infective virus particles from the culture medium we washed the cultures at least three times 
after the 1h viral exposure.  
 
Establishment of neuron/microglia and astroglia/microglia co-cultures 
In cultures used for time-lapse recordings microglial cells isolated from mixed glial cultures 
were seeded on top of astrocytic or neuronal cell cultures in 10 000 cell/cm2 density, 
immediately after the infection and the subsequent washing steps. If not CX3CR1+/GFP 
microglia were used, the cells were subjected to staining with the orange or red vital 
CellTracker dyes CMTMR/CMTPX (#C2927, #C34552, ThermoFisher Scientific) prior co-
culture establishment (30min, 37oC). 
 
Time-lapse microscopy 
Time-lapse recordings were performed on a computer-controlled Leica DM IRB inverted 
fluorescent microscope equipped with a Marzhauser SCAN-IM powered stage and a 10x N-
PLAN objective with 0.25 numerical aperture and 5.8 mm working distance. The microscope 
was coupled to an Olympus DP70 colour CCD camera and a Zeiss Colibri LED epifluorescent 
illumination system. Cell cultures were kept at 37°C in humidified 5% CO2 atmosphere in 
tissue culture grade Petri dishes in a stage-top incubator mounted on the powered stage of the 
microscope. Stage positioning, focusing, illumination and image collection were controlled 
by a custom-made experiment manager software on a PC. Phase contrast and epifluorescent 
images were collected consecutively every 10 minutes from several microscopic fields for 





Cell motility data analysis 
Cell tracking: Images were analysed individually with the help of custom-made cell-tracking 
programs (G-track and Wintrack) enabling manual marking of individual cells and recording 
their position parameters into data files. At the magnification applied, the precision of this 
tracking procedure is estimated to be 10 μm, comparable to the average cell diameter (10-50 
μm). In the following, the position of the ith cell at time t is denoted by xi(t).   
Trajectories: Cell positions, xi(t), from several microscopic fields were recorded over 24 hours 
and each cell’s trajectory was plotted. Subsequently, the starting positions of trajectories were 
aligned to the origin (x=0, y=0) and consecutive relative cell positions were plotted and 
superposed yielding groups of centered trajectories enabling the comparison of cell migration 
directionality. Trajectories in the monolayer cell cultures studied indicate a persistent random 
walk behaviour with different velocity and directional persistence.  
Displacement: The motion of individual cells is often evaluated in terms of average cell 
displacement, d, over a time period t as: 





2   
where Xi(t) denoting the center of cell i at time t, 
i
  is an average over all possible cells, and 
t0 is an arbitrary reference frame of the image sequence analysed. The empirical d(t) curves 
indicate a persistent random walk behaviour in monolayer cell cultures studied. 
Average velocity: Average cell velocity was, calculated directly from cell displacements in 
consecutive steps of cell tracking. The velocity, vi(t), of a given cell i at time t was calculated 
as  
vi(t)=|xi(t+ Dt) - xi(t)| / Dt 
where Dt is the difference of two consecutive steps of cell tracking and thus the time resolution 
data acquisition. To characterize the motility of an ensemble of cells, time-dependent average 













where the summation goes over each N(t) cell being in the cell population. Average velocity, 















where K is the number of time steps of tracking. 
 
Cytokine measurement from media of primary cell cultures 
Concentrations of IL-1α, IL-1β, TNF-α, IL-6, MCP-1, RANTES (CCL5), G-CSF and KC 
(CXCL1) were measured from conditioned media of primary neuronal, astroglial and 
microglial cell cultures by using cytometric bead array (CBA) Flex Sets (all from BD 
Biosciences, #560157, #560232, #558299, #558301, #558342, #558345, #560152, #558340, 
respectively). Measurements were performed on a BD FACSVerse machine and data were 
analysed using an FCAP Array software (BD Biosciences) as described earlier (Denes A., et 
al. 2015). The cytokine levels of conditional media were corrected for total protein 
concentrations of the samples measured by Bradford Protein Assay Kit (#50000201, Bio-Rad 
Laboratories). 
Total RNA isolation and quantitative RT-PCR 
For total RNA isolation, cell culture samples were homogenized in 500 μl TRI Reagent and 
isolation was performed using Tissue Total RNA Mini Kit according to the manufacturer's 
instructions. To eliminate genomic DNA contamination, DNase I treatment was introduced (1 
U/reaction, reaction volume: 50 µl). Sample quality control and the quantitative analysis were 
carried out by NanoDrop. cDNA synthesis was performed with the High Capacity cDNA 
Reverse Transcription Kit according to the manufacturer's instructions. The chosen primer 
sequences used for the comparative CT experiments were verified with the Primer Express 3.0 






Table 4. All primers used for quantitative PCR measurements. 
 
The primers (purchased from Invitrogen) were used in real-time PCR reaction with Fast 
EvaGreen qPCR Master Mix (Biotium, USA) on a StepOnePlus (Applied Biosystems) 
instrument. The gene expression was analysed by using the StepOne 2.3 program (Applied 
Biosystems). Amplicons were tested by Melt Curve Analysis on StepOnePlus instrument. 
Experiments were normalized to gapdh expression.  
 
 
Quantification of nucleotides and adenosine 
For quantification of ATP derivatives released by or retained in control vs. infected cells, 
embryonic (E16) primary cortical neuronal cultures were used. The cells were infected at 
DIV9. 16 hours post-infection GFP expression was visible in most cells, while the cell 
membrane integrity was not compromised and the overall viability was not reduced based on 
MTT cell viability tests. The cell culture media and the cell fractions were collected 15 min 
after media change, as it is described below. The adenine nucleotides (ATP, ADP, AMP) and 
adenosine (Ado) were determined in extracts from cells and culture media by using HPLC 
method. The medium (400 µl) was separated into a cold Eppendorf tube which contained 50 
µl of homogenization solution. The cell layer was frozen with liquid nitrogen and extracted in 
100 µl volume of ice-cold homogenization solution. The homogenization solution was 0.1 M 
perchloric acid that contained theophylline (as an internal standard) at 10 µM concentration. 
The cell extract was centrifuged at 3510 g for 10 min at 0-4oC and the pellet was saved for 
protein measurement. Perchloric anion from the supernatant was precipitated by 1 M 
GAPDH 
fw TGA CGT GCC GCC TGG AGA AA, rev AGT GTA GCC CAA GAT GCC CTT 
CAG 
IL-1α 
fw CCA TAA CCC ATG ATC TGG AAG AG, rev GCT TCA TCA GTT TGT ATC 
TCA AAT CAC 
TNF-α fw CAG CCG ATG GGT TGT ACC TT,  rev GGC AGC CTT GTG CCT TGA 
MCP-1 fw CCAGCACCAGCACCAGCCAA,      rev TGGATGCTCCAGCCGGCAAC 
RANTES fw CAGCAGCAAGTGCTCCAATCTT,   rev TTCTTGAACCCACTTCTTCTCTGG 
IL-6 fw CTCTGCAAGAGACTTCCATCC,     rev AGTCTCCTCTCCGGACTTGT 




potassium hydroxide, the precipitate was then removed by centrifugation. The culture media 
after the acid extraction was centrifuged as described above. The extracted purines were kept 
at -20oC until analysis. The adenine nucleotides and adenosine in extracts from cells and 
culture media were determined by online column switching separation using Discovery HS 
C18 50 x 2-mm and 150 x2-mm columns.  The flow rate of the mobile phases [“A” 10 mM 
potassium phosphate, 0.25 mM EDTA “B” with 0.45 mM octane sulphonyl acid sodium salt, 
8 % acetonitrile (v/v), 2 % methanol (v/v), pH 5.2] was 350 or 450 µl/min, respectively in a 
step gradient application. The enrichment and stripping flow rate of buffer [10 mM potassium 
phosphate, pH 5.2] was during 4 min and the total runtime was 55 min. The HPLC system 
used was a Shimadzu LC-20 AD Analytical & Measuring Instruments System, with an Agilent 
1100 Series Variable Wavelength Detector set at 253nm. Concentrations were calculated by 
a two-point calibration curve using internal standard method. The data are expressed as pmol 
per mg protein or pmol per mL.  
 
Enzyme histochemistry for detection of ecto-ATPase activity 
A cerium precipitation method was used for electron microscopic investigation of ecto-
ATPase activity (Kittel, 1999). Briefly, thoroughly washed sections were incubated in a 
medium containing 1 mM ATP as substrate, 3 mM CeCl3 (precipitating agent for the liberated 
phosphate), 1 mM levamisole (inhibitor of alkaline phosphatases, Amersham, Poole, UK), 1 
mM ouabain (Na+, K+-ATPase inhibitor; Merck, Darmstadt, Germany), 50 mM αβ-
methylene ADP (5’-nucleotidase inhibitor) and 5 mM KCl in 70 mM Tris–maleate buffer (pH 
7.4) for 30 min at room temperature. Incubation was followed by three rinses in Tris–maleate 
buffer and washing with distilled water. The tissue blocks were then postfixed, dehydrated 
and treated and embedded into Taab 812 resin for ultrathin sectioning and microscopic 






Flow cytometric analysis of brain, spleen and blood samples 
Cells were isolated from mouse brains by enzymatic digestion with the mixture of DNase I 
(10µg/ml, #11284932001, Roche) and Collagenase/Dispase (0,5mg/ml, #11088866001, 
Roche) in 10% FCS/DMEM, followed by several centrifugation steps with Percoll (40% and 
70%) and washing in 10% FCS/DMEM. Spleen cells were isolated by mechanical 
homogenization of the spleen and red blood cells were removed by centrifugation. Brain and 
spleen cells were diluted with FACS buffer (PBS containing 0.1% Tween 20) before 
acquisition. Venous blood was collected from the heart before transcardial perfusion using 
3.8% sodiumcitrate as an anticoagulant. For flow cytometric analysis, Fc receptor blockade 
was performed (anti-mouse CD16/CD32, 1:100, #16-0161-85, eBioScience), followed by 
labelling blood cells, splenic leukocytes or brain cells with cocktails of selected antibodies 
(Table 5.). Cells were acquired on a BD FACSVerse flow cytometer and data were analysed 
using FACSuite software (BD Biosciences). Total blood cell counts were calculated by using 
15 μm polystyrene microbeads (#18328-5, Polysciences). 
Table 5. Antibodies used for flow cytometry. 
Antigen Host species Dilution Catalogue number 
CD8a-PE anti-mouse 1:400 #12-0081-82 eBioScience 
CD3e-APC anti-mouse 1:200 #17-0032-80, eBioScience 
CD11b-PE anti-mouse 1:200 #101207, BioLegend 
Ly6C-PECy7 anti-mouse 1:400 #25-5932-80, eBioScience 
CD115-APC anti-mouse 1:100 # 17-1152-80, eBioScience 
F4/80-like 
receptor-BV421 
anti-mouse 1:200 #563900, BD Biosciences 
CD39-PE anti-mouse 1:100 #143803, BioLegend 
CD45-
PercyP5.5 
anti-mouse 1:200 #103131, BioLegend 








All quantitative measurements and analysis were performed in a blinded manner in 
accordance with STAIR and ARRIVE guidelines. Data were analysed using the GraphPad 
Prism 7.0 software. For comparing two experimental groups Student’s t test with Welch’s 
correction or Mann–Whitney U test, for comparing three or more groups one-way or two-way 
ANOVA followed by Tukey’s, Sidak’s and Dunnett’s post hoc comparison was used. P < 0.05 
was considered statistically significant. 
 







4.1. Microglia are essential for anti-viral immunity in the central nervous system 
 
4.1.1. Microglia control the spread of viral infection in the brain  
 
First we wanted to test whether microglia respond to signals originating from virus 
infected neurons in their vicinity. For this purpose, we made use of the Bartha-
DupGreen recombinant strain of Bartha-PRV derivative, which displays precisely 
controlled, retrograde transsynaptic spread to central autonomic nuclei after uptake by 
peripheral nerve endings (Fig.1.a,) (Boldogköi et al., 2004). Similar to that seen in 
previous studies, viral infection reached the hypothalamus across synaptically linked 
neurons via the sympathetic ganglia, the spinal cord and the medulla (Dénes et al., 
2006) 6 days after intraperitoneal (i.p.) virus administration. In line with the 
appearance of infected neurons in the hypothalamic paraventricular nucleus (PVN), 
Iba1 positive microglia were recruited around infected neurons (Fig.1.b, c,). 
 
 
Figure 1. Microglia are recruited to infected neurons in the CNS. a, Retrograde 
trans-synaptic spread of PRV-Bartha-DupGreen (BDG) to the hypothalamic 
paraventricular nucleus (PVN) 6 days after injection. b, Infected neurons (PRV: cyan 
blue) induce the recruitment of microglia (Iba1: yellow) in the PVN. c, Number of 
recruited microglia significantly increases at sites of virus-infection, area: 0.2 mm2 c, 








4.1.2. Selective elimination of microglia results in uncontrolled viral spread and 
neurobehavioral pathologies  
 
To investigate the role of microglia in controlling viral infection, we performed 
selective microglia depletion, by feeding mice a chow diet containing PLX5622, a 
CSF1 receptor antagonist, as described in previous studies (Szalay et al., 2016). After 
three weeks of depletion, 96% of microglia were eliminated from the CNS, as shown 
on Fig.2.a-b.. Selective elimination of microglia led to a significant increase in the 
number of infected neurons in the whole brain (Fig.2.c-d,). In the absence of microglia, 
we noticed that the number of PRV-immunopositive neurons and disintegrating 
neurons also increased three-fold, compared to that seen in the microglia competent 
infected group (Fig.2.e,). We also observed the emergence of diverse neurological 
symptoms in microglia depleted infected mice, starting on the 5th day after virus 
injection. These symptoms included heavy breathing and drooling, seizure-like 
episodes or muscle spasms, which were completely absent in control mice (Fig.2.f,). 






Figure 2. Microglia elimination results in uncontrolled viral infection and pathological 
behavioural changes. a, Selective depletion of microglia by PLX5622 for 3 weeks (Iba1: 
yellow; P2Y12: magenta). b, The depletion resulted in 96% elimination of microglia. c, An 
absence of microglia results in profound increases in virus-infected neurons in the brain. 
Control and microglia depleted mice were injected intraperitoneally with BDG on the 16th 
day of the diet and allowed to survive for 5 days to allow transsynaptic spread of PRV into 
the hypothalamus. d, The number of infected neurons in the PVN increases over twofold in 
microglia depleted mice 5 days after virus injection. Note that the numerous infected neurons 
outside the PVN are indicating increases in non-synaptic (contact) infection in the absence of 
microglia e, Absence of microglia leads to the increase of infected neurons in the PVN. f, 
Absence of microglia leads to increased number of disintegrated neurons in the PVN. g, 
Elimination of microglia results in rapidly appearing neurological symptoms 5 days after virus 
injection. (0: no symptoms, 1: heavy breathing and drooling, 2: muscle spasms and seizures). 
b, ****p <0.0001 unpaired t-test n=6 mice/group, e, f,  ****p<0.0001 Mann-Whitney test 
n=10-11 mice/group g, ****p<0.0001 Mann-Whitney test n=10-11 mice/group. Scale bars: a, 







To test whether the role of microglia in controlling viral infection would depend on the site of 
virus injection, we injected the viral construct into control and microglia depleted mice 
intraperitoneally or into the white adipose tissue of the epididymis (an organ receiving 
primarily sympathetic innervation). The results showed that both after injecting the virus into 
the epididymal white apidose tissue and i.p., the number of infected neurons were markedly 
higher in the absence of microglia. (Fig.3.). In these mice, retrograde infection even reached 
several sensory and motor cortical areas, which were not affected when microglia were present 




Figure 3. The effect of microglia depletion on the spread of virus infection in the brain. 
Bartha-DupGreen (BDG) injection into control and microglia depleted mice intraperitoneally 
(i.p.) (left side) or into the epididymal white adipose tissue (right side) results in infection in 
similar central autonomic brain areas. In microglia depleted animals number of infected neurons 
were significantly higher both with i.p. or after epididymal injection. The increased number of 
infected cells in higher cortical regions indicate that in the absence of microglia infection would 
not exclusively spread in a transsynaptic manner, but possibly also via released virus capsids 
leading to contact infection of nearby neurons. Maximum Intensity Projection from confocal Z 
stack of 5 steps were made with 3,38 µm (cortex), 0,83 µm (PVN), 4,05 µm (brainstem) step 






4.1.3. Microglia phagocytose infected neurons but are resistant to productive viral infection  
 
To investigate the nanoscale interaction between microglia and infected neurons, we 
turned to super-resolution microscopy, using the stochastic optical reconstruction 
microscopy (STORM) technology. To visualize viral proteins phagocytosed by 
microglia, cell were identified by the microglial phagosome/lysosome marker CD68 
(Fig.4.a-b,). In control mice, recruited microglia surrounded the soma of infected 
neurons tightly and the already phagocytosed neuronal parts containing viral particles 
were present inside the phagosomes (Fig.4, a, insert). The absence of microglia 
resulted in increased extracellular viral protein level and PRV-immunopositive cell 
debris (Fig.4.b,). These results were confirmed with electron microscopy as well, 
which revealed the direct contact between microglial processes and the membrane of 
infected neurons, as well as the phagocytosed parts of infected neurons (Fig.4. c-d,). 
In contrast with control (microglia competent) mice, in microglia-depleted animals we 
observed disintegrated neuronal membranes and extracellular immunogold labelled 
viral proteins (Fig.4.e-g,). In line with this, we could not detect any immediate early 
GFP signal, which is expressed by BDG or any PRV-immunopositive viral capsids 
neither in the cytoplasm, nor in the nucleus of microglia (Fig.4.h,j,). Thus, while in 
some cases neurotropic viruses can cause productive infection in myeloid cells 
(Wheeler, Sariol, Meyerholz, & Perlman, 2018a), we show that the attenuated PRV 









Figure 4. The presence of extracellular viral structural proteins increases in the absence 
of microglia. a, STORM super-resolution microscopy reveals co-localisation of 
phagocytosed infected neuronal debris with CD68-positive phagosomes (dark blue) inside 
recruited Iba1 positive (yellow) microglia. b, Microglia depletion leads to massive increase in 
extracellular virus proteins around infected and disintegrated neurons. c, Microglial process 
(yellow pseudocolor) tightly surrounds infected neuronal cell membrane (cyan pseudocolor). 
d, Infected neuronal debris containing viral capsids labelled with PRV-immunogold (black 
arrows on insert) completely  phagocytosed by microglia. e, In the absence of microglia anti-
PRV immunogold labelled virus capsids invade the extracellular space from disintegrating 
neurons. f, Infected neuron containing virus capsids (black arrowheads; black asterisk marks 
the nucleus), white arrowheads mark mature virions labelled with strong PRV-immunogold  
in the cytoplasm. g, PRV-virions are visualized at higher magnifications. h, Transmission 
electron microscopic (TEM) pictures show the presence of PRV-immunolabelling inside an 
infected cell and the complete absence in control tissue. Microglial processes (yellow 
pseudocolour) can be seen close to the neuron (cytoplasm: blue, nucleus: green pseudocolour). 
In the infected neuron high level of PRV-immunogold (black grains) can be seen, which are 
linked to viral capsids and mature virions (insert). In control neuron no PRV-labelling could 
be detected, which confirms the specificity of the antibody. j, TEM pictures show that DAB-
positive microglia (yellow pseudocolour) show the complete absence of viral capsids, and 
anti-PRV immunogold labelling. This was further confirmed with confocal microscopy 
(second panel), where, contrary to infected neurons, immediate-early GFP signal is absent in 
microglia (magenta). Scale bars: a, b, 100 µm, d, e, f, 400 nm, g, 175 nm, h-j, 1 µm, on 
confocal panels: 50 µm and 10 µm (Fekete et al. 2018). 
 
4.2. Microglia recruitment is initiated rapidly to virus-infected neurons in the brain 
 
4.2.1. Microglia are recruited to infected neurons within hours as suggested by differential 
expression of viral immediate-early and structural proteins 
 
After showing that microglia are instrumental for the control of neurotropic viral infection in 
the CNS, we aimed to investigate whether microglial recruitment occurs early enough to allow 
the isolation of infected neurons before the breakdown of neuronal cell membranes. For this 
purpose we used the immediate-early GFP marker, which is expressed by infected neurons 
prior to the production of viral proteins (Fig.5. a, b,). This feature of the virus allowed us to 
time-map the different infection phases at single neuron level (Boldogkői et al. 2004; Dénes 
et al. 2006). Early infected cells are only GFP-positive, then parallel with the decrease of 
immediate-early GFP signal, viral structural proteins start to accumulate in the cytoplasm of 
the infected neurons. This transition occurs in a few hours based on our earlier studies 
(Boldogkői et al. 2004; Dénes et al. 2006). In fact, neurons expressing only GFP (Phase I) 
were only occasionally surrounded by microglia, while cells with low levels of GFP and 
detectable levels of viral structural (PRV) proteins were already surrounded by microglia (Fig 




cytoplasm, which paralleled increases in the number of microglia around them, resulting in 
an average of 1-3 microglial cells contacting the soma of infected neurons (Fig 5. a, Phase 
III). 
 
Figure 5. Microglia rapidly isolate virus-infected neurons in the brain. a, Iba1 positive 
microglia (yellow) recruited to PRV-infected neurons that express GFP with immediate-early 
kinetics (BDG) in the hypothalamic paraventricular nucleus (PVN). Note that microglia 
recruitment starts after the expression of immediate-early marker GFP (phase I), when low 
levels of viral structural proteins become detectable (phase II). High levels of viral structural 
proteins indicate a late stage of viral infection (phase III), which is associated with higher 
number of microglia recruited to infected cells b, Parallel with the propagation of virus 
infection number of recruited microglia increases significantly. Data are expressed as mean ± 
s.e.m. b, ***p<0.001 one-way ANOVA, n=8 infected neurons/group Scale bar: a, 10 µm 
(Fekete et al. 2018). 
 
4.2.2. Imaging microglia recruitment with in vivo two-photon microscopy in real-time 
 
To be able to observe microglia recruitment in real-time, we used in vivo two-photon 
microscopy. Since microglia are very sensitive to any disturbances in the brain (Davalos et 
al., 2005a), we first optimized our surgical procedure to avoid the activation of microglia due 
to cranial window preparation. To this end, prior to two-photon imaging we thinned the skull 
bone of Cx3Cr1+/GFP reporter mice, and the following day we imaged microglial processes 
(Fig6. a,). We found that in case the dura mater remains intact upon craniotomy, microglial 
processes remain in normal homeostatic condition, comparable to that seen when imaging 
through thinned skull bone, which did not allow appropriate resolution and depth to be 




and withdrawal of their motile processes (Fig6.a, right panel). Thus, during the in vivo 
imaging studies the dura mater was always kept intact and the removed skull bone was 
replaced by glass coverslip to achieve appropriate resolution at the level of layer 2/3 neurons 
and to monitor microglial processes in real-time. To co-detect viral infected neurons with 
microglia, we used PRV-Bartha-DupDSRed (BDR) virus, allowing us to recognize early 
phases of the infection based on the production of the red fluorescent protein DSRed 
(Boldogkői et al., 2009). To investigate microglia recruitment, Cx3Cr1+/GFP microglia reporter 
mice were infected with BDR and were allowed to survive for 7 days, resulting in virus 
infection in upper layers of the cerebral cortex. With in vivo two-photon imaging, we were 
able to see the recruitment of GFP+ microglial processes, in parallel with the increase of 
DSRed signal in infected neurons within 3 hours (Fig.6.b,).  3D reconstructions of in vivo 
imaging revealed that microglial processes form a barrier-like structure, establishing several 
direct contact points with the infected neuronal soma (Fig.6.c,). Recruited microglia also 
showed increased velocity of process motility in response to local signals induced by infected 







Figure 6. Microglia form barrier around infected neuron. a, Thinned skull bone with intact 
dura mater revealed ramified microglia with in vivo two-photon imaging, however following 
durectomy microglia activated rapidly (images from, Szalaey et al. 2016). b, In vivo two-
photon imaging reveals microglial (green) recruitment to virus-infected neuron (red) in real 
time. Retrograde, transsynaptic infection was induced by BDR-injection in Cx3Cr1 +/GFP 
microglia reporter mice, 7 days prior to imaging. The infected neuron could be visualized in 
cerebral cortex via immediate-early DSRed expression. c,  Merged Z-planes of microglial 
cells around PRV-DSRed-positive neuron and recruited microglial cells (white arrows 
indicate recruited microglia, arrowheads show contact sites of microglial processes on the 
infected neuron soma). d, The velocity of recruited microglial processes increases 
significantly in response to viral infection compared to control microglia. d, *p<0.05, unpaired 








4.2.3. Neurons are directly contacted by microglia at the early phase of virus infection 
 
To further explore, whether microglia form direct contact with infected neurons in early 
phases of infection, we performed a correlated study using confocal microscopy, electron 
microscopy and electron tomography. For this purpose, we made use of Cx3Cr1+/GFP microglia 
reporter mice, and visualized microglia-neuron contact with confocal microscopy. 3D 
reconstruction of confocal Z stacks revealed microglial contact formation with infected 
neuronal soma and main dendrites prior to the appearance of mature virions in the cytoplasm 
(Fig.7.a,). The surrounding processes of microglia showed CD68-immunopositivity, 
indicating phagocytic activity (Fig.7.a,). It is important to note that we did not detect any viral 
capsids outside of phagosomes in microglial cytoplasm in any phase of viral infection 
(Fig.4.d; Fig.7.b-c,). Correlated electron tomography revealed the formation of specific 
membrane-to-membrane interactions between microglial processes and infected neuronal 
soma suggesting the early recognition and contact with the intact cell membranes (Fig.7.d,).  
We also showed on transmission electron microscopic pictures that in early phase of infection 
neuronal membranes are still intact with normal chromatin structure (Fig.7.e,). From these 
data we can conclude that microglial processes are able to sense even the early phase of 





Figure 7. Correlated study confirms direct microglia-neuron contact in the early phase 
of virus infection. a, 3D reconstruction made from deconvolved confocal Z stack uncovers 
CD68-positive (magenta) phagosomes inside recruited microglia (green) engulfing PRV-
positive infected neuronal soma (cyan). Upper insert: single image plane of the same 
confocal stack. Middle insert: 3D reconstruction of the same microglial cell, rotated 180o 
around vertical axis. White asterisk labels the place of phagocytosed soma of infected neuron. 
Lower insert: 3D reconstruction of PRV-positive infected neuronal cell body surrounded 
with phagosomes located inside microglia. b, Transmission electron micrograph shows the 
same cells on an ultrathin section matching the confocal image plane in the upper insert in a,. 
c, Enlarged insert from panel b, (white box). Intact neuronal membrane is confirming the early 
phase of infection. Note that the nucleus is loaded with viral capsids. d,  Electron tomographic 
image of a 3nm thick section and corresponding 3D reconstruction show direct membrane 
contact points between microglia (green pseudocolour) and infected neuronal cell membrane 
(cyan pseudocolor). White arrowheads point to putative contact sites, where the distance of 
the two membranes are the smallest and several filament-like structures can be observed 
connecting the two cells. e, TEM images show that microglial processes (dark DAB-
precipitate, yellow pseudocolour) find and contact infected neurons even at the early phase of 
the infection, when only low levels of anti-PRV immunogold labelling can be detected 
(cytoplasm: cyan pseudocolour, nucleus: green pesudocolour). Black arrowheads point to 
microglial process contacting infected neuronal membrane. Black arrows point to a synapse 
of an infected neuronal dendrite. Scale bars: a, 2 µm, b, 1 µm, c, 400 nm, d, 100 nm, e, 50 µm 





4.3. Virus infection triggers the recruitment and phagocytic activity of microglia in 
vitro  
 
4.3.1. Microglial responses to infection in vitro 
 
We aimed to uncover the mechanisms of microglia recruitment to sites of virus infection, so 
we established in vitro co-cultures of neurons and GFP+ microglia from Cx3Cr1+/GFP mice and 
performed 48 hour long time-lapse imaging. In control cultures, microglia scanned and 
frequently contacted the cell body and main dendrites of healthy neurons, but did not cause 
any injury or showed phagocytic activity (Fig.8.a, upper panel). Opposing this, microglia 
added to virus infected neuronal cultures displayed rapid recruitment and phagocytic activity 








Figure 8. Microglia are recruited rapidly and phagocytose virus-infected cells in vitro. a, 
Cx3Cr1+/GFP  microglia (green) frequently scan non-infected neuronal processes and cell 
bodies without hindering process outgrowth or affecting network stability. Red arrowhead 
points to an uninterruptedly growing neurite (upper panel), and microglia scanning and 
slipping under dense neuronal network (middle panel). In PRV-infected neuronal cultures 
microglia acquire an amoeboid shape and phagocytose compromised cells (bottom panel, cyan 
blue arrow).  b, Cx3Cr1+/GFP microglia (green) move freely and monitor healthy astrocytes 
contacting them regularly (upper panel). In virus infected cultures microglia recruit rapidly to 
infected astrocytes and display phagocytic activity (lower panel). Satellite images: PRV-
immunopositive cell particles (red) eaten up by a Cx3Cr1+/GFP microglial cell (green) c, 
Individual trajectories of randomly selected microglial cells are displayed after 24 hours in 
control and infected astroglial cultures. Individual cell trajectories were positioned to start 
from the origo and superimposed for better comparison of migration directionality. Insets 
show control, random walk behaviour (upper inset), and shorter, targeted directionality (red 
arrow) of phagocytic microglia (lower inset). d,  Microglial average time-dependent velocity 
in control and infected astroglial cultures. e, Average velocity of microglia decreases 
markedly in infected cell cultures over 24 hours. f,  Frequency distribution of time-dependent 
average velocities of microglia cells in control and infected astroglial cultures. g, Average 
displacement of microglia in various time intervals of migration in control and infected 
astroglial cultures. Error stripes correspond to s.e.m. Scale bars: a, 10µm; b, 25µm and 10µm, 
respectively. Data are expressed as mean± s.e.m. e, g=121 cells, unpaired t-test, 
****p<0.0001. (Fekete et al. 2018). 
 
 
4.3.2. Microglia phagocytose infected cells in vitro  
 
Next, we wanted to study microglial behaviour more precisely, which required more sparsely 
distributed cell cultures. Since this was not feasible with neuronal cultures, we took advantage 
of that astrocytes are also infected with PRV under in vitro conditions (Gönci et al., 2010). In 
fact, in sparse astrocyte cultures microglia migrated much longer distances on average to reach 
infected cells. Statistical analysis of longer cell trajectories enabled us to more effectively 
separate random migration from targeted movement of microglial cells to infected astrocytes, 
followed by localized scanning activity and phagocytosis (Fig.8.b,). As we previously 
detected in neuronal cultures, microglia recognised and phagocytosed infected astrocytes, 
which was also confirmed with immunofluorescent detection of phagocytosed cell particles 
(Fig.8.b, bottom panel and insert). This was also evidenced by individual microglia 
trajectories showing characteristic localized patterns as microglia tended to remain longer at 
sites of virus infected cells (Fig.8.c,), which was in sharp contrast with microglia trajectories 
in uninfected cultures showing random walk behaviour pattern. We associated this 
phenomenon with the reduction of cell velocities in infected cultures (16.6±3.2 µm/h in 




infected cells direct microglial migration, scanning behaviour and phagocytosis. Importantly, 
the development of productive infection was never observed in microglia neither in vivo nor 
in vitro even after the direct exposure of cells to high viral titers or following phagocytic 
activity, as evidenced by the absence of the immediate-early GFP signal and PRV proteins in 
microglial cells outside phagosomes (Fig. 4. h, j, Fig.9.). 
 
Figure 9. BDG does not induce productive infection in microglial cells in vitro. In primary 
neuronal, astroglia and microglia cultures (bottom panel) infection with Bartha-DupGreen 
(BDG) was induced 24 hours prior to the assessment of infection-induced GFP expression or 
the cell viability (MTT) assay. It is important to note that in microglia cultures productive 
infection could not be detected, whereas in neuronal and astrocyte cultures GFP signal was 
visible. The viability of microglia, astrocytes and neurons is not reduced by virus infection or 
treatment with lipopolysaccharide (LPS). Data are expressed as mean ± s.e.m. Scale bars: 50 
µm, 15 µm (Fekete et al. 2018). 
 
 
4.4. Nucleotides released from infected cells trigger microglia recruitment and 
phagocytosis via microglial P2Y12 receptors 
 
4.4.1. Neurotropic virus infection induces the production of inflammatory mediators 
 
Next, we aimed to investigate the production of inflammatory mediators induced by 
neurotropic virus infection, therefore we measured several inflammatory cytokines and 
chemokines that are commonly upregulated in response to virus infection in neuronal and 
astroglial cell cultures (Lokensgard, Cheeran, Hu, Gekker, & Peterson, 2002). As a positive 
control, we used bacterial lipopolysaccharide (LPS), which is a widely used pro-inflammatory 
stimulus. LPS treatment induced a robust increase of TNFα, IL-6, CXCL1, CCL5 (RANTES), 




However, we noticed that PRV infection increased only CCL5 levels in both cell types at 
mRNA and peptide levels 24 hours after infection (Fig.10.).  
 
Figure 10. In response to viral infection inflammatory cytokines and chemokines are 
produced by astroglia, microglia and neuronal cell cultures in vitro. a-i, Cytokine levels 
were measured 24 hours after PRV infection from conditioned medium of astroglial and 
neuronal cultures by cytometric bead array (CBA). As a positive control, LPS treatment was 
induced parallel with virus infection. For qPCR measurement cell homogenates were collected 
as well. a-f, one-way ANOVA, followed by Tukey’s post hoc test. a,****p<0.0001 Cont vs 
LPS; b, *p<0.05 Cont vs LPS; c, ***p<0.001 Cont vs LPS; d, ****p<0.0001 Cont vs LPS, 
***P<0.001 Cont vs LPS, Cont vs PRV, *p<0.05 Cont vs LPS; e, ****p<0.0001 Cont vs LPS, 
**p<0.01 Cont vs LPS;  f, ****p<0.0001 Cont vs LPS;  g-i, two-way ANOVA followed by 
Sidak’s multiple comparisons test; h, ****p<0.0001 BDG vs LPS; i, ****p<0.0001 BDG vs 







4.4.2. Release of purinergic nucleotides triggers rapid microglia activation 
 
Since synthesis and release of chemokines could last for several hours and our in vivo data 
suggested rapid microglia recruitment to sites of virus infection, we checked whether purine 
nucleotides such as ATP that are chemotactic for microglia could be released from infected 
cells at a short time scale (Davalos et al., 2005a). We found that cultured neurons released 
ATP after virus infection, which was associated with reduced ATP, ADP, AMP and adenosine 
levels in cell lysates within hours (Fig.11.a,b,) upon the expression of the immediate-early 
marker GFP, which precedes the expression of viral structural proteins required for productive 
infection (Dénes et al., 2006). The changes in purinergic metabolites were associated with 
increased ecto-ATPase levels in infected cells (Fig.11.c,) but were not due to apoptosis or 
necrosis, since at the early stages of infection neurons expressing high levels of GFP showed 
no uptake of propidium iodide (PI) (Fig.11.g,h,). In addition, increased ecto-ATPase levels 
and NTDPase1 expression were found in microglia at sites of virus infection in the brain, 
indicating that microglia respond to changes in the levels of purine nucleotides (Fig.11,d,e,)  









Figure 11. Microglia react to nucleotides released upon viral infection. a, and b, graphs 
show that ATP, ADP, AMP and adenosine levels were measured with HPLC analysis in the 
supernatant (a) and in cellular fractions (b) of control and virus-infected neuronal cell cultures 
. c, Enzyme histochemistry and densitometric analysis of ecto-ATPase show that the enzyme 
activity increased markedly upon infection. d, Electron microscopic image shows NTDPase1 
expression of microglia (red) in PRV-infected brain. NTDPase1+ microglia is in contact with 
a disintegrating PRV-immunopositive neuron (blue). e, NTDPase1+ microglia in control and 
infected brains. f, Densitometric analysis of NTDPase1 enzyme, measured from control and 
infected mouse brains. g, h, Propidium iodide (PI, red), was used as viability marker to show 
that neuronal death in cell cultures was not increased 16 hours after infection. All data are 
expressed as mean ± s.e.m a-b, n=4 cell culture per group, unpaired t-test, *p<0.05; **p<0.001 
c, n=6 cell culture per group, unpaired t-test, ***p≤0.001 f, n=7 brain slice per group, unpaired 
t-test, **p<0.01. Scale bars: c, 25 µm; d, 50 µm; e, 10 µm; g, 50 µm (Fekete et al. 2018). 
 
 
4.4.3. Microglia recruitment to infected neurons is mediated by P2Y12 receptors in vitro  
 
To further investigate the mechanisms mediating microglial responses to purinergic 
nucleotides we established co-cultures of P2X7-/- or P2Y12-/- microglia and wild type 
astrocytes. Similar to that seen in wild type microglia, motility of P2X7 deficient cells 
decreased when exposed to infected cells (Fig.8.a,b,) and trajectories showed characteristic 
localized pattern due to regular scanning activity, suggesting that P2X7 deficiency does not 
impede recognition of virus-infected cells by microglia (Fig.12.e,). In contrast, virus exposed 
P2Y12-/- deficient microglia showed marked increase in their motility (Fig.12.f-j,) with 
trajectories characteristic of random walk behaviour and lacking the localized pattern. 
(Fig.12.k,). This suggests that these cells are unable to display targeted recruitment in response 
to viral infection. Moreover P2Y12-deficient microglia showed very low phagocytic activity 
in virus exposed environment, compared to wild type and P2X7-/- microglia that showed 
marked increase in phagocytosis (Fig.12.l-n,). Thus, P2Y12 is a key contributor in recognition 





Figure 12. Microglial recruitment and phagocytosis are mediated by purinergic 
signalling upon virus infection. a, and f, Time-dependent average velocities of P2X7 (nc=67, 
ni=74) and P2Y12 (nc=51, ni=59) deficient  microglial cells in control and infected astroglia 
cultures. Decreased velocity of P2X7-/- and the lack of such decrease of P2Y12-/- microglia 
cells can be detected in infected cultures. b, and g, Average velocities of P2X7-/- and P2Y12-
/- microglia over 24 hours in control and infected astrocyte cultures. c, and h, Frequency 
distribution of time-dependent average velocities of P2X7-/- and P2Y12-/- microglial cells in 
control and infected astroglial cultures. d, and j, Average displacement of P2X7 and P2Y12 
deficient microglia in different time intervals of migration in control and infected astroglial 
cell cultures. Error stripes correspond to s.e.m. e, and k, Individual trajectories of equal 
number (n=50) randomly chosen P2X7-/- and P2Y12-/- microglial cells over 24 hours in control 
and infected astrocyte cultures. For better comparison of migration directionality individual 
cell trajectories were centered to start from the origo. P2X7-/- microglia showed more localised 
migration pattern and scanning activity in infected cultures compared to the random walk 
behaviour under control condition. P2Y12-/- microglial cells showed the absence of this 
localised scanning behaviour in their trajectories in infected cultures. l, Phagocytic activity of 
wild type (WT), P2X7  and P2Y12 deficient microglia. Expression of immediate-early GFP 
marker can be seen in infected astrocytes. Red arrowheads point to phagocytosed, infected 
cells. m-n, Percentage of phagocytic events by wild type, P2X7-/- and PY12-/- microglia. Note 
that P2Y12 deficient microglial cells are unable to phagocytose infected cells. b and g, n=121 
cell per group, unpaired t-test, ****p<0.0001. m and n, n=9 cells per group, one-way 





4.5. Microglial P2Y12 receptors mediate recruitment of microglia and elimination of 
virus infected cells in vivo 
 
4.5.1. Microglial P2Y12 receptors form clusters when contacting the cell membranes of 
infected neurons 
 
Next, we investigated whether nucleotides released from compromised neurons are involved 
in the recruitment of microglia in vivo. We found that all microglia surrounding the soma and 
the processes of infected neurons in either C57BL/6 or Cx3Cr1+/GFP mice expressed P2Y12 
receptors. (Fig.13.a-c,). STORM super-resolution microscopy allowed us to monitor the 
changes in the localization and amount of P2Y12 receptors at 20 nm lateral resolution. We 
found that microglial P2Y12 receptors formed clusters at sites, where microglial processes 
contacted infected neuronal cell bodies directly (Fig.13.d,). Inside clusters, the number of 
receptors increased two-fold in response to virus infection (Fig.13.f,). However, microglial 
processes of the same cells, which did not come in contact with infected neurons did not show 
the clustering of P2Y12 receptors, neither did the receptor numbers increase within the 
clusters. This suggests that microglial P2Y12 clustering is contact specific around infected 
neurons (Fig.13.e,g,h,), which may be an integral part of microglial scanning behaviour at 





Figure 13. Microglial P2Y12 receptors form clusters when contacting the cell bodies of 
infected neurons. a, Fluorescent images show that P2Y12 receptors are specifically 
expressed by microglia in the CNS. Every microglial cell co-expresses the 
microglia/macrophage marker Iba1 with P2Y12. b, Iba1 and P2Y12 markers are expressed by 
all microglia. c, P2Y12-positive microglia are recruited to infected neurons in the brain. 
Recruited microglia (magenta) contact virus-infected neuronal soma and dendrites (green). d, 
STORM super-resolution images reveal P2Y12 receptors clustering (cyan blue dots) at 
microglial cell membrane directly contacting infected neurons. Neurons were identified by 
GFP expression with immediate-early kinetics, indicating early stage of virus infection. e, 
STORM images uncovered that clustering of P2Y12 receptors is associated with formation of 
physical microglia-neuron contact. On distant microglial processes P2Y12 receptors do not 
form clusters (middle panel). f, Based on the analysis of STORM images, P2Y12 localisation 
point (NLP) numbers are markedly increased at microglia-neuron contact sites, when 
microglia are contacting infected neurons compared with microglia touching non-infected 
cells. g-h, STORM analysis of P2Y12 clusters and localisation points (NLP) on whole, 
contacting and distant microglia membrane surface. All data are expressed as mean ± s.e.m. 
b, ns=not significant; f, ***p<0.001 unpaired t-test n=7-13 cells per group; g, *p<0.05 one-
way ANOVA, ***p<0.001 one-way ANOVA; h, **p<0.01, ****p<0.0001 one-way 






4.5.2. Microglia recruitment is impaired in the absence of P2Y12 receptors in vivo, but 
neurological symptoms are not augmented by P2Y12R deficiency 
 
To investigate the contribution of P2Y12 receptor-mediated activities and purinergic 
signalling of microglia to the defence against viral infections in vivo, we induced viral 
infection in P2X7-/- and P2Y12-/- mice (Fig.14.a,). We found that the lack of P2Y12 resulted 
in an over 50% reduction of microglia recruitment (Fig.14. e,) to infected neurons in the PVN 
(Fig.14. b,c, p<0.05), whereas the absence of P2X7 receptor showed a non-significant trend 
in reduction (by 35 %) of recruited microglia compared to wild type mice (Fig14.d,). Similar 
to what we have seen in microglia-depleted mice (Fig2.d,), the number of infected neurons 
containing viral structural proteins increased over three-fold in P2Y12-/- mice. In contrast lack 
of P2X7 receptors did not influence the spread of virus infection in the brain (Fig.14.b,c,). 
Interestingly, we observed that clusters of microglia at sites of virus infection in P2Y12-/- mice 
were located in the close vicinity of disintegrated, PRV-immunopositive neurons, suggesting 
that P2Y12 deficiency markedly impairs microglial responses to signals released from 
infected neurons and comprises phagocytic responses, but does not fully block microglial 
migration to already disintegrated cells  (Fig.14.d,e,). Despite of the increased number of 
infected neurons in P2Y12 receptor deficient mice, we did not observe any neurological 
symptoms, suggesting that the absence of microglia (Fig.2.g,), but not microglial P2Y12 could 





 Figure 14. P2Y12 receptor mediates microglial recruitment and phagocytosis in 
response to virus infection in vivo. a, Confocal fluorescent pictures show the spread of 
infection in the paraventricular nucleus of the hypothalamus in wild type, P2X7-/- and P2Y12-
/- mice. Immunostaining against PRV structural proteins (cyan blue) revealed neurons in the 
late state of the infection and recruited microglia around them, labelled with Iba1 (yellow). b-
c, In P2Y12-/- animals the numbers of PRV-immunopositive neurons were markedly increased 
compared to that seen in wild type and P2X7 receptor deficient animals. d-e, In P2Y12 
deficient mice significantly less microglia were recruited to infected neurons compared to 
wild type and P2X7 receptor deficient mice. f, Lack of P2Y12 receptor did not result in any 
neurological symptoms 6 days after virus infection. area: 0.2 mm2. 3V - 3rd ventricle. All data 
are expressed as mean ± s.e.m. b,d, n.s=not significant. c, **p<0.01 Mann-Whitney test, n=7 
animals per group e, *p<0.05 n=7 animals per group unpaired t-test. Scale bar: a, 50 µm 





To test for the possible mechanisms underlying the controversies concerning the role of 
microglial P2Y12 in the spread of infection, but a lack of an effect in neurological outcome 
compared to microglia-depleted mice, we designed a new study, which enabled direct 
comparison of control, P2Y12-/- and microglia depleted mice after virus infection. In this 
experiment, we could again confirm our previous results that in P2Y12-/- mice there is 
deficient recruitment of microglia to infected neurons. As we detected earlier, both the absence 
of P2Y12 and microglia depletion caused a significant increase in the numbers of virus 
infected and disintegrated neurons (Fig.15.a-c,). However, the neurological symptoms only 
emerged in microglia-depleted animals (Fig.15.d,). In contrast, levels of extracellular virus 
proteins were identical in P2Y12-/- and microglia-depleted mice, while markedly increased 
compared to control mice (Fig.15.e,f,). P2Y12-/- microglia showed significantly lower levels 
of CD68-positive phagosomes compared to that seen in control mice, indicating the lack of 










Figure 15. P2Y12 deficiency leads to impaired phagocytosis but does not exacerbate 
neurological symptoms in vivo. a, Parallel comparison of PRV-immunopositive neurons in 
control, P2Y12 deficient and microglia depleted mice. P2Y12-/- phenotype shows lack of 
microglia (yellow) recruitment to infected neurons (cyan blue) (satellite images). b, Highest 
number of disintegrated neurons were detected in microglia depleted mice, but P2Y12-/- mice 
also showed a marked increase in disintegrating cells. c, Total number of PRV-
immunopositive neurons was markedly higher in microglia depleted and P2Y12 deficient 
animals compared to control group. d,  Absence of P2Y12 does not cause any neurological 
symptoms 5 days after virus infection, which could be seen in microglia depleted animals (0: 
no symptoms, 1: drooling and heavy breathing, 2: seizures and muscle spasms). e, STORM 
super-resolution microscopy reveals elevated levels of extracellular PRV proteins in microglia 
depleted and P2Y12 deficient mice compared to wild type group. f, Quantitative analysis of 
extracellular level of PRV proteins on STORM images. g, In control Cx3cr1+/GFP and P2Y12 
deficient (Cx3cr1+/GFP x P2Y12-/-) microglia CD68-positive phagosomes (magenta) were 
visualized. Lack of CD68, can be seen in P2Y12 deficient microglia compared to control cell. 
h, P2Y12-/- microglia show significant decrease of CD68-positive phagosomes compared to 
wild type microglia (CD68 immunofluorescent integrated density/GFP immunofluorescent 
integrated density within microglial cell bodies, p=0.0322, Mann-Whitney U-test, n=35 cells/ 
16 ROIs). Data on d, expressed as median and interquartile range, otherwise as mean± s.e.m. 
b, c, d, Mann-Whitney U-test, n=5-6 animals per group. Scale bars: a, 100 µm e, and g, 2 µm. 
All data expressed as mean± s.e.m. b, Control vs P2Y12 *p< 0.05; Control vs Depleted 
****p<0.0001; P2Y12 vs Depleted **p<0.01, One-Way ANOVA c, Control vs P2Y12 
**p<0.001; Control vs Depleted ****p<0.0001; P2Y12 vs Depleted ****p<0.0001 One-Way 
ANOVA d, Control vs Depleted ****p<0.0001; P2Y12 vs Depleted ****p<0.0001 One-Way 
ANOVA  f, Control vs Depleted p**< 0.01; Control vs P2Y12 ***p< 0.001 One-Way 
ANOVA (Fekete et al. 2018). 
 
4.6. Microglia recruit leukocytes into the brain upon virus infection independently 
of P2Y12-mediated signalling 
 
4.6.1.P2Y12-mediated signalling does not affect leukocyte recruitment during viral infection 
 
Previous studies have shown that following virus infection blood-borne cells are recruited into 
the brain (Rassnick et al., 1998). In light of this information, we wondered whether P2Y12-
mediated actions of microglia are involved in neuroinflammatory changes in the present 
experimental model. As expected, numerous CD45high immunpositive leukocytes were 
recruited to sites of virus infection (Fig.16.a,). Based on the higher CD45 expression, we could 
clearly discriminate blood-borne infiltrated leukocytes from microglia. The absence of 
microglia/macrophage marker Iba1 and microglia specific P2Y12 signal further confirmed 
this (Fig.16.b,). Next, we investigated whether purinergic signalling via microglial P2Y12 
receptors contributes to leukocyte infiltration. Using immunofluorescent labelling, we found 
that the number of CD45-positive blood-borne leukocytes did not change in P2Y12 deficient 




characterized recruited leukocyte populations. Most of the infiltrated leukocytes were 
CD45high, Cx3Cr1+, CD11b+, Ly6Chigh cells, which markers are characteristic for monocytes 
(Fig.16.d-e,). Although P2Y12-mediated mechanisms play a major role in controlling the 
spread of virus infection, we concluded that the absence of P2Y12 does not impair leukocyte 







Figure 16. Leukocyte infiltration upon PRV infection is independent of P2Y12 signalling. 
a, Fluorescent pictures show CD45-positive (orange) leukocyte recruitment to PRV-
immunopositive neurons in the PVN in wild type and P2Y12 deficient mice. b, P2Y12-
expressing (magenta)microglia were clearly separated  from blood-borne cells highly 
expressing CD45 (orange), most of which were also negative for microglia/macrophage 
marker Iba1 (blue). c, Numbers of infiltrated leukocytes show no significant difference in 
control and P2Y12-/- mice, area:0.2 mm2. d, Flow cytometric dot plots show that microglia 
(Cx3Cr1high, CD45low, Ly6C-, Ly6G- cells, P8) can be well characterized and clearly separated 
from infiltrated monocytes (Cx3Cr1int, CD45high, Ly6Chigh, Ly6G- cells, P9) during viral 
infection in the brain. e, Flow cytometric dot plots show infiltrated monocytes (P5) in the 
brain. f, Microglial numbers do not change in response to virus infection compared to control 
condition. g, Monocytes are recruited into the brain in response to virus infection in P2Y12 
receptor deficient mice. All data expressed as mean ± s.e.m. f, n.s.= not significant g, 
****p<0.0001 n=4 brains per group unpaired t-test. Scale bars: a,b, 50 µ (Fekete et al. 2018). 
 
 
4.6.2.Selective depletion of microglia influences leukocyte infiltration in virus infected brain 
 
In contrast with our previous results in P2Y12-/- animals, selective elimination of microglia 
surprisingly resulted in a marked decrease in CD45-positive leukocytes around virus infected 
areas in spite of the increased number of infected neurons in the brain (Fig.17.a,). It is 
important to note that the lack of leukocyte infiltration in microglia-depleted animals was not 
due to the drug, PLX5622 itself, as it was also confirmed earlier with another CSF-1R 
inhibitor, PLX3397  (Szalay et al., 2016). Treatment with PLX5622 was not associated with 
any significant changes in circulating or splenic myeloid cell populations including 
granulocytes and monocytes, while lymphocytes were not affected either in microglia-
depleted animals, compared to controls (Fig.20.). Using FACS analysis we uncovered that 
from all infiltrated CD45-positive cell populations, CD45high, Cx3Cr1+, CD11b+, Ly6Chigh 
monocyte numbers were markedly reduced in microglia depleted, virus infected animals 
(Fig.17.c-e,). To further elaborate on the mechanisms through which microglia may recruit 
monocytes, we showed that microglia exposed to high titers of PRV in vitro produced CCL5 
(RANTES) and MCP-1 (a chemokine to recruit monocytes/macrophages), whereas CCL5 and 
IL-1a were reduced markedly in hypothalamus homogenates of microglia depleted, virus 
infected mice (Fig.18.). Note that extensive virus infection in the brain was also associated 
with increased number of circulating granulocytes in microglia-depleted mice, suggesting that 
peripheral myeloid populations were capable of responding to central viral infection, but the 
recruitment to the brain was inhibited by the absence of microglia (Fig.20.). Next, we aimed 
to investigate the causes behind the absence of the inflammatory Ly6Chigh monocyte 




infiltration is augmented by blood-brain barrier (BBB) injury (Benakis, Garcia-Bonilla, 
Iadecola, & Anrather, 2015). Surprisingly, we could not detect any significant difference in 
the integrity of BBB between microglia depleted infected and control infected animals. For 
further explanation, we made use of Intercellular Adhesion Molecule 1 (ICAM) to 
fluorescently label activated vessels in infected areas, which did not show any difference 
between microglia depleted infected and control infected PVN regions (Fig.19.).   
 
 
Figure 17. Recruitment of leukocytes to the brain is diminished in response to virus 
infection in the absence of microglia. a, Immunofluorescent pictures show that recruitment 
of CD45-positive leukocytes (orange) can be detected in virus infected PVN which is 
markedly reduced in microglia depleted, infected animals. b, Leukocyte numbers are 
significantly lower in microglia depleted animals. c,  Flow cytometric dot plots show the 
almost complete absence of microglia in depleted animals (P4). Despite of the adverse virus 
infection in the absence of microglia, CD45high, Cx3Cr1+, CD11b+, Ly6Chigh monocyte (P5) 
recruitment is profoundly reduced in microglia depleted, virus infected animals. d, 
Cx3Cr1+/GFP microglia are markedly reduced in the brain after 3 weeks of PLX5622 diet. e, In 
response to virus infection, monocyte numbers increase significantly in control brain, but are 
reduced in microglia depleted mice. All data expressed as mean ± s.e.m b, ****p<0.0001 
unpaired t-test n=12 animals per group; d, control vs depleted ****p<0.0001, control inf. vs 
depleted inf. ****p<0.0001 One-Way ANOVA; e, control vs control inf. **p<0.01, control 






Figure 18. Changes in inflammatory cytokines and chemokines in response to virus 
infection and selective elimination of microglia. Left, in vitro data: Cytokine and chemokine 
levels were measured in the conditioned medium of microglial cell cultures by cytometric 
bead array after LPS treatment or exposure to PRV. Samples were collected 24 hours after 
infection. Right, in vivo data: Cytokine and chemokine levels were measured from 
homogenates of hypothalamic brain tissues of control and microglia-depleted mice infected 
with PRV in a retrograde transneuronal manner, 5 days prior to sample collection. All 
measurements have been performed by cytometric bead array. Data are expressed as mean ± 
s.e.m. One-way ANOVA, n=5 animals and cell cultures per group (Fekete et al. 2018). 
 
Figure 19. Depletion of microglia does not influence blood-brain barrier injury during 
virus infection. a, Number of ICAM positive activated blood vessels did not show significant 
difference in control infected and microglia depleted infected PVN asreas. b, , ICAM positive 







Figure 20. Selective depletion of microglia does interfere with main blood cell 
populations. Cx3Cr1+/gfp mice were fed a PLX5622 chow diet for 21 days to deplete 
microglia. On the 16th day of the diet, a group of mice were injected with Bartha-DupGreen 
(BDG). Blood samples were collected from control mice and from mice 5 days after virus 
infection with or without microglia depletion, and labelled with mixtures of specific 
antibodies against leukocyte markers followed by flow cytometric analysis. Total blood cell 
counts were calculated by using 15 µm polystyrene microbeads (Polybead Microspheres, 
18328-5). The number of CD8- (P5 gate) T lymphocytes, CD11b+ Ly6c+ SSChigh Ly6G+ 
granulocytes (P8 gate), CD11b+ Ly6chigh Cx3Cr1+ (Ly6G-) monocytes (P7 gate) and MHCII+ 
CD11b- B cells (P18 gate) were no different between control, depleted, control infected and 
depleted infected animals. In association with the profoundly increased CNS infection in 
microglia depleted mice, numbers of CD3+ CD8+ T lymphocytes (P4 gate) and CD11b+ Ly6c+ 
SSChigh Ly6G+ granulocytes (P8 gate) showed significant difference between depleted and 
depleted virus infected animals. Data are expressed as mean ± s.e.m. one-way ANOVA, n=4 







4.7. Recruitment of P2Y12-positive microglia and leukocytes in human herpes 
simplex encephalitis  
 
To investigate microglia recruitment and neuroinflammatory changes in the human brain, we 
analysed temporal lobe samples from patients with herpes simplex type 1 virus (HSV-1) 
encephalitis, in which infection had been confirmed both by PCR and immunohistochemistry, 
as reported earlier (Csonka et al., 2013). Similarly, to what we have seen in PRV infected 
mice brain tissue, in human samples both HSV-1 and HSV-2 infected neurons were 
surrounded by P2Y12-positive microglia cells (Fig21.a, Table 2.). We confirmed this further 
with another specific microglial marker, Tmem119 (Fig.21.b,). Infected cells were, contacted 
by 1-3 microglia (on average 1.5 microglia/ HSV-1+ cell (Fig21.c,). CD68 labelling in 
recruited amoeboid cells indicated active phagocytosis at sites of virus infected neurons 
(Fig.21.d,). Microglia showed negative results for HSV antigens suggesting that viral 
infection does not develop in these cells. With CD45-immunohistochemistry and Giemsa 
staining, we identified recruited leukocytes in close proximity to HSV1-positive neurons. 
Leukocytes were also negative to Tmem119 and P2Y12, so they could be clearly 
discriminated from recruited microglial cells (Fig.21.e-g,). Interestingly, we observed strong 
correlation between the number of recruited leukocytes and the amount of HSV-1 infected 
neurons (Fig.21.h,). At areas of HSV-1 infection we detected low amount of CD3-positive 
lymphocytes, CD20-positive B cells and CD15-positive myeloid cells (Fig.21.i,). ). In the 
absence of HSV1 infection, the vast majority of Iba1-positive microglia was found to be 
P2Y12 positive (96%) and numbers of Tmem119-positive and P2Y12-positive microglia were 
similar in the brain parenchyma (Fig.22). We also noticed that moderate HSV infection (less 
than 50 HSV-1-positive cells/mm2) was associated mostly with the activation of local 
microglia, which were positive for P2Y12 and Tmem119. In the same areas, amoeboid or 
ramified CD68-positive cells were also observed. In advanced HSV-1 infected (50-500 HSV-
1-positive cells/mm2) brain tissue, increased number of CD45-positive cells were recognised 
in the brain parenchyma, which was associated with markedly increased numbers of CD68-
positive macrophages. In line with this, the number of ramified microglia, and the total number 





Figure 21. Microglia and leukocytes are recruited to HSV-1 infected neurons in the 
human brain. a, P2Y12-positive microglia recruited to HSV-1 infected neurons (brown, 
visualized by NovaRED HRP  substrate). Recruitment of microglia to neurons in different 
stages of infection are visualized (arrows, visualized by DAB-Ni) in the human cerebral 
cortex. P2Y12-positive microglial processes contact HSV-1 positive neurons (i-iii). In the 
absence of detectable HSV antigens microglia are displaying amoeboid, phagocytic 
morphology (iv). b, Tmem119 expressing microglia are recruited around HSV-1 infected 
neurons (i) and phagocytose HSV-positive cells (ii). c, Average number of P2Y12-positive 
and Tmem119-positive microglia contacting infected neurons. d, CD68 expressing brain 
macrophages (DAB-Ni) surround HSV-1 infected neurons (NovaRED). e, Virus infection is 
associated with leukocyte infiltration (arrowheads) visualised by Giemsa staining (i) and 
CD45 immunostaining (ii) parallel with activated microglia (arrows) labelled with P2Y12 (i) 




morphology near blood vessels suggests both blood-borne and resident origin of brain 
phagocytes. f, In infected areas, neurons surrounded by P2Y12-positive microglia are 
associated with recruited CD45-positive leukocytes (g). h,  Leukocyte numbers in infected 
areas show correlation with the number of HSV-1 infected neurons. p<0.0001, linear 
regression, n=64 FOV, from 5 patients. i, CD15-positive myeloid cells, low amount of CD3-
positive lymphocytes and CD20-positive B cells could be observed at infected brain areas. j, 
Moderate HSV-1 infection is associated with the presence of P2Y12-positive, Tmem119-
positive microglia and CD68-positive microglia/macrophages, whereas the number of P2Y12-
positive and Tmem119-positive microglia is decreased during advanced infection, while the 
number of CD68-positive macrophages significantly increases in the parenchyma. k, 
Quantitative representation of P2Y12-positive, Tmem119-positive microglia and CD68-
positive brain macrophages in moderate and advanced HSV-1 infection. bv – blood vessel. 
Scale bars: a, b, d, f, g, h, i - 10μm; e and j - 50μm. k, *p<0.05, **p<0.01, ***p<0.001 (Fekete 
et al. 2018). 
 
Figure 22. Microglia express P2Y12 in the human brain. a, Co-localization of microglial 
P2Y12 and Iba1 on perfusion-fixed, free-floating brain sections (frontal cortex). b, Proportion 
of P2Y12-positive microglia among Iba1+ cells. c, Immunohistochemistry showing 
Tmem119-positive and P2Y12-positive microglia in paraffin-embedded brain sections 
(frontal cortex). d, Quantification of Tmem119-positive and P2Y12-positive microglia in the 






Figure 23. Advanced HSV-1 infection is associated with marked neuroinflammatory 
responses in the human brain. Recruitment of numerous CD45-positive cells and CD68-
positive brain macrophages is seen at sites of advanced virus infection characterized by large 








My studies have demonstrated that microglial P2Y12-mediated responses are essential for 
the recognition and effective elimination of compromised neurons after virus infection that 
reaches the brain exclusively via retrograde transsynaptic spread. Microglia recruitment 
occurs within a few hours in vivo and leads to the phagocytosis of infected cells. Marked 
increases in the number of disintegrated cells and leakage of viral antigens into the 
extracellular space are seen in the absence of functional microglia, which are associated 
with exaggerated infection and the development of neurological symptoms. These results 
also show that P2Y12 receptors are key drivers of microglial phagocytosis both in vivo and 
in vitro and that microglial P2Y12 is essential for appropriate responses to nucleotides 
released by infected neurons in the brain. Furthermore, my research identify microglia as 
key inducers of monocyte recruitment into the brain in response to neurotropic virus 
infection and also demonstrate the relevance of these findings in the human brain. We also 
uncovered that the mechanisms through which microglia contribute to monocyte recruitment 
are largely independent of the extent of blood-brain barrier injury in this experimental 
model.  
 
5.1. Regulation of inflammatory responses during neurotropic viral infections 
 
Neurotropic virus infections continue to cause major disease and economic burdens on 
society, and pose major challange to both human and animal health due to associated 
morbidity and mortality worldwide. Finding effective treatment opportunities to control 
infection burden during CNS infections is still an unsolved problem, largely due to the unique 
and complex features associated with reduced immune surveillance and limited regeneration 
capacity of the CNS. Infection by neurotropic viruses and immune responses induced by 
activated microglia and recruited peripheral immune cells can irreversibly disrupt the complex 
structural and functional architecture of the CNS, often leaving patients or affected animals 
with various neurological conditions that may contribute to long-term cellular damage or 
death. Once a pathogen invades the brain, microglia and astrocytes are considered to provide 
the first line of defense, although evidence from functional studies is presently incomplete. In 
addition to central immunocompetent cell types, peripherally recruited innate (monocytes, 
neutrophils) and adaptive (CD8+ T cells, CD4+ T cells, B cells) immune cells are known to be 




an inherent confounder to this response upon neurotropic viral infections, infiltrating immune 
cells are also known to contribute to immune-mediated pathologies, mainly via the production 
of multiple inflammatory mediators, such as pro-inflammatory cytokines and chemokines 
(Getts et al., 2013) 
Neutrophils are among the first blood-borne immune cells to infiltrate into the parenchyma 
upon virus infection. Similarly to that seen in non-communicable diseases such as in the case 
of stroke (Planas, 2018) or TBI (Donat et al., 2017) neutrophils start to appear in the brain 
parenchyma within hours upon infection. Impaired trafficking or depletion of neutrophils is 
capable of reducing the size of the lesion after stroke or TBI, especially when acute brain 
injury is combined with systemic inflammation (McColl et al., 2006), Similar effect of 
neutrophil depletion on reduced brain injury has been described during West-Nile virus 
infection. In these studies, impaired neutrophil responses resulted in limited immune cell 
crossing through blood-brain barrier and neuropathology was diminished, however, the spread 
of viral infection was not inhibited (Wang et al. 2012).   
Different monocyte subsets are also known to be recruited into the infected brain within hours 
or days and contribute to central inflammatory responses, although their functional role in 
limiting viral infections is presently not well defined. According to studies, which have used 
HSV-2 (Iijima, Mattei, & Iwasaki, 2011), coronavirus (Becker et al., 2008) or MHV (Chen 
BP  et al. 2001) infection models, Ly6Chi monocytes appear to play paradoxical role. In case 
of encephalitic disease, such as TMEV infection, it was shown that recruited Ly6Chi 
monocytes contribute to the immunopathogenesis of disease. Inhibition of inflammatory 
monocyte migration resulted in TMEV-infected brain significantly reduced morbidity and  
mortality (Ajami, Bennett, Krieger, Tetzlaff, & Rossi, 2007). Chemokines produced by 
resident immune cells or early infiltrating blood-borne myeloid cell types in the infected brain 
are known to be major contributors to mounting inflammatory responses via promoting the 
recruitment of T cells and B cells into the CNS. For example, the production of CXCL10 and 
CCL5 promotes the migration and accumulation of CD4+ and CD8+ T cells in the brain that 
control viral replication via secretion of IFN-γ (Miller et al., 2016). In line with this, it was 
shown in a model of HSV-1 infection that CD8+ T cells become activated and contribute to 
the restriction of HSV-1 replication 8 days after infection in mice. In cytomegalovirus (CMV) 
infected patients, acyclovir treatment, which is an anti-viral drug with activity against a range 
of herpes viruses and is used as long term treatment to suppress reactivation of  HSV, resulted 
in reduced T cell response (mainly CD4+ T cell reaction) to viral antigens, however immune 




In a mouse hepatitis virus (MHV) model, delayed depletion of CD4+ T cells did not alter CD8+ 
T cell recruitment  into the brain, but impaired their IFN-γ production, resulting in impaired 
cell survival and uncontrolled increase of viral titers. Thus, while peripheral immune cells 
contribute to immune responses in the CNS, it is assumed that the main coordinators of these 
processes are resident microglia. However, due to the trafficking of massive amounts of 
macrophages and monocytes into the infected brain, studies to selectively investigate the 
potential role of microglia regulating responses in anti-viral immunity could not come to clear 
conclusions due to the absence of selective approaches to influence microglial responses until 
very recently (Elmore et al., 2014). In addition, most models of CNS infection or injury that 
require direct manipulation of the CNS microenvironment inherently include non-specific 
microglial activation, which makes studying microglial responses to infection-related signals 
difficult. 
 
5.2. Pseudorabies virus infection as an ideal model for studying microglia-mediated 
inflammatory responses 
 
Transsynaptic spread, self-amplification and borad host range made pseudorabies virus an 
ideal tool in an extensive number of neuroanatomical studies (Strack AM 1994; Card et al. 
2014) seeking to define the architecture of multisynaptic pathways. In order to control the 
speed and virulence of the virus, attenuated derivatives of PRV-Barthta were developed. 
Further genetical manipulation, by inserting various fluorophores (GFP, DSRed) inside the 
genome of the virus made possible to precisely follow the infection in time (Boldogkői et al. 
2003).  To establish a model of neuronal injury in which microglial responses to local signals 
can be studied within a realistic time frame and without in situ manipulation of the brain 
microenvironment, we have used genetically modified PRV-Bartha derivatives, which 
exhibit precisely controlled, retrograde transneuronal spread but do not infect microglia 
(Boldogkői et al. 2003; Dénes et al. 2006). These recombinant PRV strains also allowed 
precise time-mapping of the spread of infection due to the expression of reporter proteins 
with different kinetics (Taylor, Kobiler, & Enquist, 2012). At the same time, we could 
investigate the functional contribution of microglia to neurotropic herpesvirus infection, 
which has not been previously investigated using selective elimination of microglia.  
Since immune surveillance by circulating immune cells is restricted in the brain parenchyma 
(Prinz & Priller, 2014a), early recognition of infection by microglia is likely to be critical to 




neurotropic herpesviruses including microglial activation and recruitment of blood-borne 
immune cells has been previously characterized by excellent earlier studies. Our former data 
has also shown that microglia surround infected neurons in the brain (Dénes et al., 2006). 
Recent reports highlighted the importance of central type I interferon responses against 
vesicular stomatitis virus and herpes simplex virus type 1 implicating microglia as a source 
of inflammatory mediators in anti-viral immunity in the brain (Chen, Zhong, & Li, 2019). 
However, the kinetics and the mechanisms of microglia recruitment to infected cells have 
remained unexplored to date, similarly to the need for understanding phagocytic activity by 
microglia to control the spread of infection.  
 
 
5.3. Microglia sense various danger signals coming from compromised neurons 
 
During neurotropic virus infection, compromised neurons release various danger signals into 
the extracellular space, which trigger inflammatory processes. Danger signals released by 
injured neurons such as DNA, heat shock proteins or ATP act as potent activators of microglia 
and also contribute to the outcome in different brain pathologies (Stevens & Schafer, 2018). 
However, the exact signals mediating early recognition of injured cells and those inducing 
phagocytosis of compromised neurons by microglia are poorly defined. In addition, the 
mechanisms of microglial decision-making regarding the fate of injured neurons is unclear.  
A number of studies have demonstrated that purinergic signaling plays an important role in 
CNS injury responses (Davalos et al., 2005b). Intravital microscopy (IVM) studies revealed 
that focal laser injury in the brain induces purinergic receptor-dependent projections of 
microglia toward the injury site, which help the clearance of cellular debris, and facilitate 
lesion containment. Similarly, nucleotides are released following TBI, that trigger a robust 
microglial response dependent on purinergic receptor (P2X4, P2Y6, P2Y12) signalling (Fields 
& Burnstock, 2006). However, due to the complexity of these pathways and the immediate 
response of microglia to any tissue disturbance, it is difficult to dissect the mechanisms 
through which microglia recognize stressed neurons in most known experimental models of 
brain injury. Our PRV model combined with selective microglia depletion and P2Y12R 
specific KO lines allowed us to study the involvelement of purinergic signaling in the context 






5.4. Nucleotides released from compromised neurons cause immediate response 
from microglia and sensed via microglial P2Y12 receptor 
 
Infected cells, including neurons and microglia were reported to sense HSV-1 via cytoplasmic 
DNA sensors, namely the adaptor protein stimulator of type I IFN genes (STING) (Reinert et 
al. 2016; McCarthy, Tank, and Enquist 2009) However, the signals initiating microglia 
recruitment to infected neurons in the absence of microglial infection had remained unclear. 
Our in vivo and in vitro data suggest that soon after the development of productive infection, 
purinergic mediators released from neurons recruit the processes of uninfected microglia in 
their vicinity, followed by the displacement of the cells, leading to the formation of tight 
membrane to membrane interactions with the infected neurons. Since PRV infection alters 
neuronal activity (McCarthy et al., 2009) we hypothesised that the earliest signals from 
infected neurons to microglia are more likely to include mediators regulating rapid microglia-
neuron interactions in vivo than de novo production of inflammatory chemokines. 
Specifically, noxious stimuli in neurons can trigger a sustained increase of extracellular ATP, 
which results in microglial activation and recruitment within minutes to hours (Fields & 
Burnstock, 2006). In fact, our data show that purine nucleotides released from affected 
neurons contribute to microglial process extension, cell migration to infected neurons and 
subsequent phagocytic activity via microglial P2Y12 receptors. ATP released from injured 
cells leads to the activation of P2-type and adenosine receptors upon extracellular ATP 
catabolism by ecto-nucleotidases (Rodrigues, Tomé, & Cunha, 2015). In line with this, we 
observed increased ecto-ATPase levels and NTDPase1 activity in infected cells and microglia. 
ATP is a strong chemotactic signal for microglia in vivo and hydrolysis of ATP to ADP, which 
is the main ligand for P2Y12 takes place by ecto-nucleotidases within minute (Sperlágh & 
Illes, 2007) In turn, increased P2Y12 receptor levels were found on microglial processes 
contacting infected neurons, as assessed by super-resolution microscopy. Since infected 
neurons at the stage of immediate-early reporter protein expression are viable and 
electrophysiologically active (re(McCarthy et al., 2009)f), these results also imply that 
microglia are well-equipped to identify injured neurons way earlier than the integrity of the 
cell membranes is compromised. Our ultrastructural analysis and in vitro data also confirm 
this, showing normal cell membrane integrity until late stages of virus infection. Thus, in spite 
that P2Y12 has been implicated earlier in the recruitment of microglia to sites of tissue injury 




cell-autonomous effect of P2Y12 on microglia to rapidly recognize and eliminate infected 
neurons for the first time. We also show that P2X7, which plays a major role in microglial 
inflammatory responses and cytokine production (Sperlágh & Illes, 2014) is dispensable for 
anti-viral immunity in this experimental model.  
 
5.5. Microglia are essential to limit neurotropic virus infection in the brain 
 
To understand better the specific role of microglia in response to viral infections has been 
challenging due to the presence of non-microglial myeloid cells with potentially overlapping 
functions in the healthy brain and by the rapid infiltration of hematopoietic myeloid cells into 
the parenchyma during inflammation. Although many studies have described microglial 
functions such as the production of proinflammatory mediators or phagocytosing dying or 
injured cells, none of them could determine the exact contribution of microglial responses to 
neurotropic virus infection. In line with this, using in vitro and in vivo models of P2Y12 -/- 
mice, our results showed that this purinergic receptor play crucial role in microglial 
phagocytosis of infected cells, however the question whether microglia participate actively in 
controlling viral infection have remained unclear. In order to investigate this question we 
made use of selective microglia depleting tool, the CSF1-R inhibitor drug, called PLX5622. 
In line with other recent studies using the same microglia elimination model in other 
neurotropic virus infection models, such as mouse hepatitis virus (MHV) (Wheeler et al. 2018) 
and West-Nile virus (Seitz et al. 2019) have made the same conclusions, that absence of 
microglia would result in increased mortality and depletion in a later phase of infection had 
no influence on survival (Chen et al., 2019). These data indicate, that microglia play an 
important role in controlling viral replication and reducing mortality in the early stage of 
infection (Fig. 24.). Similarly what we have confirmed earlier with PRV infection (Dénes et 
al. 2006; Fekete et al. 2018) another study, using intranasal somatitis virus (VSV) infection, 
have found activated microglia accumulating around infected olfactoy bulb neurons formed 
an immune barrier, which plays an important role in limiting the spread of VSV in the CNS 
and preventing lethal encephalitis (Steel et al., 2014). In our model, the absence of microglia, 
also resulted in non-synaptic spread of pseudorabies, resulting advanced infection in higher 
cortical areas. This also indicates, that microglial barrier formation is essential in controlling 
viral escape from already compromsied cells. In conclusion, our data obtained both in vivo in 
real time and in vitro shows that the rapid and precisely controlled migration of functional 




elimination of infected neurons is essential to prevent contact infection and to control the 
leakage of viral particles and antigens into the brain parenchyma. 
 
 
5.6. Selective microglia elimination, but not P2Y12 deficiency leads to adverse 
neurological symptoms in PRV infected mice 
 
We found that although P2Y12 is essential for the recognition and elimination of infected 
neurons by microglia, microglia depletion, but not P2Y12 deficiency led to characteristic 
neurological symptoms in virus infected mice. In line with this, microglia-depleted mice had 
higher numbers of infected / dying neurons than that seen in P2Y12-/- mice, while the levels 
of extracellular virus proteins were not different, although significantly increased in both 
groups compared to control mice. Thus, the rapidly deteriorating neurological outcome seen 
in microglia-depleted animals may be partially due to the markedly increased neuronal 
infection and to the absence of potentially neuroprotective microglial mediators, such as 
interleukin-10 (Garcia et al., 2017). While our data show that P2Y12-dependent mechanisms 
are instrumental to limit neurotropic virus infection in the brain, additional microglial 
receptors could also contribute to this process. The rapidly worsening neurological symptoms 
of mice in the absence of microglia, but not in P2Y12-deficient mice, may be due to both 
exaggerated infection and the lack of microglial factors that control neuronal activity in the 
injured brain (Stevenson, Austyn, & Hawke, 2002), which should be investigated in further 
studies. Since the PRV Bartha-Dup strains show highly specific neurotropism in vivo 
(Szpara, Kobiler, & Enquist, 2010) and we did not find any sign of hematogenous 
dissemination of infection or immunopositivity to viral antigens in the liver or the spleen 
even after PLX5622 treatment, a major role of peripheral immune mechanisms in the 






5.7. Leukocyte infiltration in virus infected brains is influenced by microglia, but is 
independent from P2Y12 receptor mediated processes 
 
We also identify microglia as key contributors to monocyte recruitment to the brain during 
virus infection. Previous studies have implicated activated microglia in leukocyte recruitment 
into the brain upon virus infection, and showed that antibodies to CXCL10 and CCL2 (MCP-
1) reduce the migration of murine splenocytes toward HSV-infected microglia in vitro 
(Marques, Hu, Sheng, & Lokensgard, 2006). In our experimental model, elimination of 
microglia by CSF1R blockade was highly selective, as it did not have a significant impact on 
circulating and splenic leukocytes (including myeloid cell types) and infection-induced 
increases in circulating granulocytes was preserved in PLX5622-treated mice. In contrast, 
recruitment of monocytes to the brain was almost completely abolished in microglia-depleted 
mice. In these studies, we made use of both CD45 and Cx3Cr1 as markers to reliably 
discriminate microglia (CD45low, Cx3Cr1high, Ly6c- cells) from monocytes (CD45high, 
Cx3Cr1+, Ly6chigh cells) without the need of complex BM chimeric studies that inherently 
include changes in BBB function and may cause microglia activation (Wilkinson et al., 2013). 
Importantly, microglial P2Y12 was essential to mediate microglia recruitment and 
phagocytosis, but was dispensable for monocyte recruitment to the brain. These data suggest 
that other microglial chemotactic factors (such as MCP-1 or RANTES) could be responsible 
for driving leukocyte migration to sites of infection and injury in the brain, which should be 
investigated in further studies. Since monocyte recruitment in P2Y12-/- mice was identical to 
that seen in control animals, but both an absence of microglia and P2Y12 deficiency resulted 
in markedly enhanced spread of infection, blood-borne monocytes may not significantly limit 
viral spread in the current experimental model. A similar conclusion was presented in a model 
of corona virus infection induced by direct injection of the virus into the brain, in spite that 
reduction of microglia numbers was associated with higher number of blood-borne 
macrophages in this study (Wheeler, Sariol, Meyerholz, & Perlman, 2018b).  Since P2Y12-/- 
mice showed comparable leukocyte infiltration to control animals, while microglia depletion 
markedly influenced leukocyte responses, a role for blood-borne cells in shaping 
neurobehavioral symptoms seen in this experimental model cannot be fully excluded. In 
contrast, other studies using PLX5622, CSF-1 antagonist combined with various neurotrop 
viral infection models did not come to the same conclusion as our results show, regarding the 




microglia depletion via CSF1R inhibitor treatment only affected the number of infiltrated 
CD45-positive cells 3 days after post infection, but no differences were observed 7 days after 
infection, indicating that recruitment of blood-derived cells was not exclusively microglia 
dependent (Wheeler et al., 2018b). However, in a model of WNH infection it was shown that 
depletion of microglia alters, but not abolish the numbers of CD4+ T cells to viral infection 
(Bergmann, Ramakrishna, Kornacki, & Stohlman, 2014). Depletion of microglia in the same 
infection model can also result in the loss of major MHCII-expressing cell type, which also 
result in decreased expression of MHC II in incoming monocytes and macrophages. In line 
with those data, our results indicate that loss of microglia affect adaptive immune response, 
resulting in a reduced virus-specific reaction of infiltrating immune cells. 
 
5.8. BBB injury is not markedly affected by the absence of microglia during viral 
infection 
 
Since we found that microglial responses are involved in leukocyte recruitment during virus 
infection, we examined whether this may be due to differences in BBB permeability that may 
also be influenced by microglial actions. Blood-brain barrier is a complex structure, which 
separates the brain microenviroment from the systemic circulation and regulates homeostasis. 
The neurovascular unit is an essential functional part of the BBB, which is composed from 
different cell types, including astrocytes, pericytes, perivascular macrophages, endothelial 
cells and microglia as well (Thurgur & Pinteaux, 2018). A large pool of brain resident 
microglia, also known as perivascular microglia, are located at the proximal region 
surrounding the cerebrovasculature, allowing close contact with endothelial cells (ECM). 
Others have already demonstrated that endothelial-microglia interactions are essential for 
angiogenesis and other vascular processes and that the microglia-vascular interface acts as a 
sensor of central or peripheral disturbance and inflammation, constituting the first line of 
defence of the CNS against injury.  
Microglia adjacent to the cerebral blood vessels are in a constant bi-directional 
communication with endothelial cells to exert their surveying functions on the intergrity of 
the BBB, as well as the influx of blood derived molecules into the brain. Several studies have 
described that in response of inflammation or injury microglia produce a large array of 
inflammatory mediators, including cytokines (interleukin (IL)-1, IL-6, tumor necrosis factor-
alpha (TNFA)), chemokines (CCL, CX3CL1, MIP-1) and proteases (matrix metalloproteases, 




parenchyma (Benakis et al., 2015). In diseased states, the vascular endothelium in the brain 
and the surrounding ECM undergo profound changes, including the breakdown of TJs, 
remodelling the ECM and enzymatic degradation of ECM proteins by MMPs contributing to 
a leaky BBB that facilitates the infiltration of systemic circulating blood-derived molecules 
and immune cells. Vascular endothelial cells (ECMs) also produce a large array of 
inflammatory mediators (CX3CL1, CCL2) which contributes to tight junction (TJs) 
breakdown, enzymatic degradation of ECM proteins by MMPs and reactive oxygen species 
(ROS) resulting in a ‘leaky’ BBB. Inflammatory cytokine measurements from microglia 
depleted, virus infected paraventricular nucleus of the hypothalamus (PVN) homogenates 
have already implicated marked changes in cytokine levels, which promted us to investigate 
the extent of BBB disruption in these animals (Lopes Pinheiro et al., 2016). Although our data 
showed that selective microglia elimination, by CSF-1 antagonist, PLX5622 diminished 
monocyte recruitment into the brain parenchyma during viral infection, an absence of 
microglia did not alter the extent of BBB injury based on IgG staining. Immunofluorescent 
detection of intercellular adhesion molecule-1 (ICAM) on activated endothelial surface has 
also shown that an absence of microglia during viral infection does not influence vascular 
activation. This is interesting since the number of virus infected neurons and also extracellular 
virus particles were increased in the infected brain of microglia depleted animals, which could 
in theory also alter BBB injury or vascular activation by shaping vascular inflammatory 
responses. Thus, our results suggest that an absence of microglia does not markedly influence 
BBB injury in this experimental model. Therefore, the mechanisms behind diminished 
monocyte infiltration are currently unclear, although decreased levels of certain cytokines, 
including Il-1α, IL-1ß, CX3CL1, MCP-1 or RANTES in the absence of microglia further 
implicate the involvement of microglia and possibly other cell types of the NVU in this 






5.9. P2Y12-positive microglia interact with infected neurons in human HSV-1 
encephalitis  
 
In addition to that seen in mice, we found that P2Y12-positive microglia were found 
recruited to HSV-1 infected neurons in human post-mortem brain tissues and phagocytosis 
of these cells by microglia was also observed, which was associated with increased numbers 
of CD68-positive brain macrophages in infected areas. As seen in mice, histological 
characterization of these post-mortem samples suggests that P2Y12-positive microglia isolate 
infected neurons, while decreased numbers of microglia and a marked increase in leukocyte 
recruitment was associated with more severe infection. The implications of these data for 
neurological diseases are far-reaching. The findings that microglia control neurotropic virus 
infection via P2Y12 in mice and the recruitment of P2Y12-positive microglia to HSV-1 cells 
was observed in the human brain suggest that microglial P2Y12 could play in general an 
important role in anti-viral immunity in the CNS  
 
Figure 24. Summary of neuroinflammatory changes in the brain after virus infection. In 
wild type mice, microglia recruitment around PRV infected neurons are observed, which is 
associated with monocyte recruitment at sites of virus infection. ATP released by infected 
neurons are cleaved by CD39 leading to stimulation of P2Y12 receptors and act as a trigger 
for microglia recruitment and phagocytosis. Lack of microglia lead to significant increase of 
infected neurons and result the complete absence of monocyte recruitment. The absence of 
P2Y12 receptors on microglia, lead to reduced recruitment of microglial cells compared to 
control animals, suggesting pivotal role of P2Y12 receptor in this process, whilst monocyte 






Beyond infectious diseases caused by alphaherpesviruses such as PRV in swine or HSV-1 
in humans, other viruses such as rabies, Zika virus, Alphaviruses, West-Nile virus, Epstein 
Barr virus, Influenza A viruses, and Enteroviruses can exhibit neurotropism and cause 
diverse neuropathologies in both humans and rodents (Koyanagi et al. 2017; Vermillion et 
al. 2017). Recent studies have also identified several links between the presence of latent 
neurotropic virus infections and their contribution to neurodegenerative disorders. Human 
herpes viruses, such as Herpes simplex 1 has the ability to disseminate in the CNS and enter 
a stage of latency, that allows long-term persistence. Latent neurotropic viral infections are 
known to alter several molecular mechanisms in the host cell, including DNA methylation, 
RNA synthesis, as well as levels of inflammatory and cell death-associated caspases and 
other enzymes in the cytosol (Zhou, Miranda-Saksena, & Saksena, 2013). These processes 
may interfere with several processes involved in aging and neurodegeneration such as 
production of misfolded proteins, lysosomal and mitochondrial function or autophagy. In 
case of HSV-1, there is strong evidence, that the virus alters the production and degradation 
of amyloid inside compromised neurons, eventually contributing to the progression of 
Alzheimer’s disease (Fraser, Pisalyaput, & Tenner, 2010). The emerging role of neurotropic 
viruses in many forms of neurodegeneration (Kierdorf & Prinz, 2017) and the common 
molecular fingerprints of cellular injury sensed by microglia in different brain patholgies 
suggest that understanding the mechanisms through which microglia control the elimination 
of injured neurons in the brain could facilitate the development of targeted therapies in 







Microgial cells are the resident immune cells of the CNS, comprising 5–10% of the total cell 
number in the brain. Their dynamic processes are constantly surveying the parenchyma and 
detect changes in neuronal activity via sensing purines, cytokines, chemokines, amino acids, 
and inorganic compounds. Microglia are not only important in maintaining the homeostasis 
of the brain but also respond to injury, infection and neurodegenerative processes through 
proliferation, morphological changes and secretion of a variety of pro/anti-inflammatory 
factors - depending on the nature of the damage (Salter & Stevens, 2017). One of the common 
challenges targeting the brain’s defense system is viral infection, which can either be latent 
persistsing for the life of the host or virulent, resulting in encephalitis causing high morbidity 
and mortality. The mechanisms, however, through which the brain’s immune system 
recognizes and controls viral infections propagating across synaptically linked neuronal 
circuits have remained unclear. In line with previous studies (Card et al., 1994; Dénes et al., 
2006) using a well-established model of neurotropic alphaherpesvirus infection that reaches 
the brain exclusively via retrograde transsynaptic spread from the periphery, we have shown 
that microglia are recruited to and isolate infected neurons within hours. Our data, obtained 
from in vitro and in vivo studies show that microglia recruitment and clearance of infected 
cells require cell-autonomous P2Y12 signaling in microglia, triggered by nucleotides released 
from affected neurons. We also demonstrate that selective elimination of microglia by CSF1R 
blockade results in a marked increase in the spread of infection and egress of viral particles 
into the brain parenchyma. In line with this, we report, that microglia depletion, but not P2Y12 
deficiency leads to characteristic neurological symptoms in virus-infected animals. We show, 
that loss of microglia results in the absence of recruitment of blood-borne leukocytes 
indicating that microglial cells contribute directly to leukocyte recruitment to the brain during 
virus infection. We demonstrate that this happens in a P2Y12 receptor independent way. We 
also identify P2Y12 mediated microglial recruitment in human HSV-1 encephalitis infected 
brain tissue and reveal that both microglial responses and leukocyte numbers correlate with 
the severity of infection. Taken together, our data reveal a key role for microglial P2Y12 in 
defence against neurotropic viruses, whilst P2Y12-independent actions of microglia may 
contribute to neuroinflammation by facilitating monocyte recruitment to the sites of infection. 
Understanding the mechanisms of microglial control of the fate of infected neurons could 
facilitate the development of targeted therapies in several common brain diseases, where the 






Neurotropic herpesviruses can establish lifelong infection in humans and contribute to severe 
diseases including encephalitis and neurodegeneration. Understanding immune mechanisms 
that are initiated in response to viral infection in the CNS is essential to develop appropriate 
therapies. As the main immune cell type of the brain parenchyma, microglial cells are known 
to be rapidly recruited to the sites of injury or infection. In previous studies, we have 
demonstrated that microglia form barriers around virus-infected cells in the brain. However, 
the functional role of microglia in defense against neurotrophic viral infection and 
mechanisms controlling microglia recruitment to infected neurons remained unclear. 
Using a well-established model of alphaherpesvirus infection that reaches the CNS 
exclusively via retrograde transsynaptic spread from the periphery we have investigated the 
propagation of viral infection and the inflammatory responses of microglial cells without 
mechanical manipulation of the brain. Selective elimination of microglia resulted in a marked 
increase in the spread of viral infection and egress of virus particles into the brain parenchyma, 
which was associated with multiple neurological symptoms. We show that microglia 
recruitment already occurred in the early stage of virus infection, when compromised neuronal 
membranes are still intact, indicating that release of chemoattractant molecules, such as ATP, 
may act as an early signal of injury. By using various in vitro and in vivo techniques we 
showed that microglial recruitment and clearance of infected cells require P2Y12 signaling, 
which is triggered by ATP and other nucleotides released by compromised neurons. We also 
identify microglia, as key contributors to inflammatory monocyte recruitment into the infected 
brain, which process is largely independent of the presence of the P2Y12 receptor. In HSV-1 
infected human brain tissue we show that microglia express the P2Y12 receptor and are 
recruited to infected neurons in the human brain during viral encephalitis. We demonstrate 
further that microglial responses and leukocyte numbers correlate with the severity of 
infection both in mouse and the human brain. Our data indicate that microglia play a pivotal 
role in controlling viral infections in the brain. Furthermore, the emerging role for neurotropic 
viruses in various forms of neurodegeneration suggests that understanding the mechanisms 
through which microglia control neurotropic viral infections could facilitate the development 






A neurotróp vírusfertőzések súlyos problémát okoznak világszerte, mivel képesek akár évekig 
lappangó, látens fertőzést kialakítani, valamint olyan súlyos betegségeket okozni, mint az 
agyvelő- vagy agyhártyagyulladás. Emellett számos neurodegeneratív betegség 
kialakulásához járulhatnak hozzá. A neurodegenerációs folyamatokhoz a gyulladás 
következtében aktiválódó mikroglia sejtek, és a perifériáról toborzódó immunsejtek által 
kiváltott különböző immunmechanizmusok nagyban hozzájárulnak. Ezért is fontos 
megértenünk, hogy hogyan is vezérli a mikroglia a sérülés, vagy fertőzés hatására kialakuló 
immunfolyamatokat a központi idegrendszerben. Korábbi kutatásunk során megmutattuk, 
hogy a mikroglia képes izolálni a vírussal fertőzött neuronokat. Habár az alapvető antivirális 
immunfolyamatok részben ismertek az agyban, a mikroglia toborzódás pontos mechanizmusai 
továbbra sincsenek feltérképezve. Kutatásunk során a herpeszvírusok családjába tartozó 
neurotróp Pseudorabies vírust (PRV) használtunk, amely kizárólag retrográd, transszinaptikus 
úton terjed a perifériás ganglionokból a központi idegrendszerbe, így az agy mechanikus 
manipulációja nélkül tudjuk a fertőzés következtében kialakuló mikrogliális immunválaszt 
vizsgálni.  Kimutattuk, hogy szelektív mikroglia depléciót követően a vírusfertőzés mértéke 
szignifikánsan megnő, valamint a fagocitózis hiányában a vírus partikulumok az 
extracelluláris térbe kerülnek, amely súlyos neuropatológiás tüneteket eredményez. 
Megállapítottuk, hogy a mikroglia toborzódás már a fertőzés korai szakaszában megkezdődik, 
amikor a fertőzött neuronok membránja még inktakt, azaz a fertőzött neuronok már ebben a 
stádiumban kibocsáthatnak kemotaktikus molekulákat. In vitro és in vivo módszerek 
segítségével megmutattuk, hogy a mikroglia toborzódás és fagocitózis P2Y12 receptor függő, 
amit a fertőzött neuronokból felszabaduló ATP és más nukleotidok aktiválnak. Kimutattuk, 
hogy a mikroglia kulcsfontosságú szerepet játszik a gyulladás következtében kialakuló 
leukocita infiltráció koordinálásában is. Ezen folyamat független a P2Y12 receptor 
jelenlététől. Megfigyeltük, hogy mikroglia depletált, vírusfertőzött állatokban a vér-agy gát 
sérülés ellenére sem történik leukocita infiltráció, amelyből arra következtettünk, hogy a 
mikrogliának ebben a folyamatban kiemelten fontos szerepe lehet. Kimutattuk, hogy humán 
HSV-1 enkefalitiszt követően a P2Y12 pozitív mikroglia toborzódik a fertőzött neuronokhoz. 
A mikroglia toborzódás és az infiltrálódott leukocita szám korrelál a fertőzés súlyosságával 
mind egér, mind emberi agyban. Eredményeink ezúton hozzájárulhatnak célzott terápiás 
módszerek kifejlesztéséhez a központi idegrendszert érintő neurotróp vírusfertőzések és 
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